,i #aadth ,,congress #b;d ,session ,h4 ,r4 #eahi ,,in ,,the ,,house ,,of ,,representatives ,may #aa1 #bjaf ,ms4 ,kuster introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committees on the ,judiciary1 ,veterans' ,affairs1 ,education and the ,workforce1 ,ways and ,means1 ,armed ,services1 and ,natural ,resources1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to address the opioid abuse crisis4 #a4 ,short title2 table of contents 7a7 ,short title ,this ,act may be cited as the ,opioid ,abuse ,crisis ,act of #bjaf4 7b7 ,table of contents ,the table of contents is as follows3 ,sec4 #a4 ,short title2 table of contents4 ,title ,i--,public ,health ,provisions ,sec4 #aja4 ,funding for opioid and heroin abuse prevention and treatment4 ,sec4 #ajb4 ,opioid overdose reversal drugs prescribing grant program4 ,sec4 #ajc4 ,partial fills of schedule ,,ii controlled substances4 ,sec4 #ajd4 ,opioid use disorder treatment modernization4 ,sec4 #aje4 ,nurturing and supporting healthy babies4 ,sec4 #ajf4 ,improving treatment for pregnant and postpartum women4 ,sec4 #ajg4 ,assisting veterans with military emergency medical training to meet requirements for becoming civilian emergency medical technicians4 ,sec4 #ajh4 ,information materials and resources to prevent addiction related to youth sports injuries4 ,sec4 #aji4 ,lali's ,law4 ,sec4 #aaj4 ,opioid review modernization4 ,sec4 #aaa4 ,study on treatment infrastructure4 ,sec4 #aab4 ,national youth recovery initiative4 ,sec4 #aac4 ,building communities of recovery4 ,title ,,ii--,comprehensive ,opioid ,abuse ,reduction ,sec4 #bja4 ,comprehensive opioid abuse grant program4 ,sec4 #bjb4 ,audit and accountability of grantees4 ,sec4 #bjc4 ,veterans treatment courts4 ,sec4 #bjd4 ,emergency ,federal law enforcement assistance4 ,sec4 #bje4 ,opioid ,program ,evaluation ,act4 ,sec4 #bjf4 ,good ,samaritan ,assessment ,act4 ,title ,,iii--,promoting ,responsible ,opioid ,management and ,incorporating ,scientific ,expertise ,sec4 #cja4 ,short title4 ,subtitle ,a--,opioid ,therapy and ,pain ,management ,sec4 #caa4 ,guidelines on management of opioid therapy by ,department of ,veterans ,affairs and ,department of ,defense and implementation of such guidelines by ,department of ,veterans ,affairs4 ,sec4 #cab4 ,improvement of opioid safety measures by ,department of ,veterans ,affairs4 ,sec4 #cac4 ,strengthening of joint working group on pain management of the ,department of ,veterans ,affairs and the ,department of ,defense4 ,sec4 #cad4 ,review1 investigation1 and report on use of opioids in treatment by ,department of ,veterans ,affairs4 ,subtitle ,b--,patient ,advocacy ,sec4 #cba4 ,community meetings on improving care furnished by ,department of ,veterans ,affairs4 ,sec4 #cbb4 ,improvement of awareness of patient advocacy program and patient bill of rights of ,department of ,veterans ,affairs4 ,sec4 #cbc4 ,comptroller general report on patient advocacy program of ,department of ,veterans ,affairs4 ,subtitle ,c--,complementary and ,integrative ,health ,sec4 #cca4 ,expansion of research and education on and delivery of complementary and integrative health to veterans4 ,sec4 #ccb4 ,pilot program on integration of complementary alternative medicines and related issues for veterans and family members of veterans4 ,subtitle ,d--,fitness of ,health ,care ,providers ,sec4 #cda4 ,additional requirements for hiring of health care providers by ,department of ,veterans ,affairs4 ,sec4 #cdb4 ,provision of information on health care providers of ,department of ,veterans ,affairs to ,state ,medical ,boards4 ,sec4 #cdc4 ,report on compliance by ,department of ,veterans ,affairs with reviews of health care providers leaving the ,department or transferring to other facilities4 ,subtitle ,e--,other ,veterans ,matters ,sec4 #cea4 ,audit of ,veterans ,health ,administration programs of ,department of ,veterans ,affairs4 ,title ,,iv--,improving ,safe ,care for ,preventing ,infant ,abuse and ,neglect ,sec4 #dja4 ,short title4 ,sec4 #djb4 ,best practices for development of plans of safe care4 ,sec4 #djc4 ,state plans4 ,sec4 #djd4 ,data reports4 ,sec4 #dje4 ,monitoring and oversight4 ,sec4 #djf4 ,rule of construction4 ,title ,v--,other ,provisions ,sec4 #eja4 ,programs to prevent prescription drug abuse under ,medicare parts ,c and ,d4 ,sec4 #ejb4 ,exclusion of authorized generic drugs from calculation of average manufacturer price for brand name drugs4 ,i ,public ,health ,provisions #aja4 ,funding for opioid and heroin abuse prevention and treatment 7a7 ,funding ,there are authorized to be appropriated1 and are appropriated1 out of monies in the ,treasury not otherwise obligated1 #fjj1jjj1jjj for fiscal year #bjag1 to improve opioid prescribing practices and expand access to substance use treatments to reduce opioid use disorders and overdose1 to be made available in accordance with this ,act4 7b7 ,state targeted response cooperative agreements ,subpart #a of part ,b of title ,v of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bij;bb et seq47 is amended by inserting after section #eji the following3 #eaj4 ,state targeted response cooperative agreements 7a7 ,in general ,the ,secretary shall enter into additional targeted response cooperative agreements with ,states under this title to expand opioid treatment capacity and make services more affordable to those who cannot afford such services4 7b7 ,awarding of funding ,the ,secretary shall allocate funding to ,states under this section based on-- 7#a7 the severity of the opioid epidemic in the ,state2 and 7#b7 the strength of the strategy of the ,state to respond to such epidemic4 7c7 ,use of funds ,amounts received by a ,state under this section shall be used to expand treatment capacity and make services more affordable to those who cannot afford such services and to help individuals seek treatment1 successfully complete treatment1 and sustain recovery4 7d7 ,funding ,of the amounts appropriated under section #aja7;a7 of the ,opioid ,use ,disorder ,treatment ,expansion and ,modernization ,act for fiscal year #bjag1 #dfj1jjj1jjj shall be made available to carry out this section1 to remain available until expended4 4 7c7 ,treatment for prescription drug abuse and heroin use ,section #cca7;b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bed;d7b77 is amended by adding at the end the following3 7#c7 7,a7 ,the ,secretary shall use amounts made available under subparagraph 7,b7 to support enhanced loan repayment awards to increase the number of clinicians in the ,corps with medication assisted treatment training to treat individuals with opioid use disorders through loan repayments to clinicians4 7,b7 ,of the amounts appropriated under section #aja7;a7 of the ,opioid ,use ,disorder ,treatment ,expansion and ,modernization ,act for fiscal year #bjag1 #be1jjj1jjj shall be made available to carry out this section1 to remain available until expended4 4 7d7 ,evaluation of medication-,assisted treatment ,subpart #a of part ,b of title ,v of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bij;bb et seq47 is amended by inserting after section #eaj1 as added by subsection 7b71 the following3 #eaa4 ,evaluation of medication-assisted treatment 7a7 ,in general ,in order to assess the treatment outcomes of patients with opioid addiction receiving medication-assisted treatment1 the ,secretary shall evaluate the short1 medium1 and long-term outcomes of such substance abuse treatment programs in order to increase effectiveness in reducing opioid use disorders1 overdose1 and death4 7b7 ,funding ,of the amounts appropriated under section #aja7;a7 of the ,opioid ,use ,disorder ,treatment ,expansion and ,modernization ,act for fiscal year #bjag1 #ae1jjj1jjj shall be made available to carry out this section1 to remain available until expended4 4 #ajb4 ,opioid overdose reversal drugs prescribing grant program 7a7 ,establishment 7#a7 ,in general ,not later than six months after the date of the enactment of this ,act1 the ,secretary of ,health and ,human ,services may establish1 in accordance with this section1 a five-year opioid overdose reversal drugs prescribing grant program 7in this section referred to as the grant program74 7#b7 ,maximum grant amount ,a grant made under this section may not be for more than #bjj1jjj per grant year4 7#c7 ,eligible entity ,for purposes of this section1 the term eligible entity means a federally qualified health center 7as defined in section #ahfa7;aa7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7aa7771 an opioid treatment program under part #h of title #db1 ,code of ,federal ,regulations1 any practitioner dispensing narcotic drugs pursuant to section #cjc7;g7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;g771 or any other entity that the ,secretary deems appropriate4 7#d7 ,prescribing ,for purposes of this section1 the term prescribing means1 with respect to an opioid overdose reversal drug1 such as naloxone1 the practice of prescribing such drug-- 7,a7 in conjunction with an opioid prescription for patients at an elevated risk of overdose2 7,b7 in conjunction with an opioid agonist approved under section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 for the treatment of opioid abuse disorder2 7,c7 to the caregiver or a close relative of patients at an elevated risk of overdose from opioids2 or 7,d7 in other circumstances1 as identified by the ,secretary1 in which a provider identifies a patient is at an elevated risk for an intentional or unintentional drug overdose from heroin or prescription opioid therapies4 7b7 ,application ,to be eligible to receive a grant under this section1 an eligible entity shall submit to the ,secretary of ,health and ,human ,services1 in such form and manner as specified by the ,secretary1 an application that describes-- 7#a7 the extent to which the area to which the entity will furnish services through use of the grant is experiencing significant morbidity and mortality caused by opioid abuse2 7#b7 the criteria that will be used to identify eligible patients to participate in such program2 and 7#c7 how such program will work to try to identify ,state1 local1 or private funding to continue the program after expiration of the grant4 7c7 ,use of funds ,an eligible entity receiving a grant under this section may use the grant for any of the following activities1 but may use not more than #bj percent of the grant funds for activities described in paragraphs 7#d7 and 7#e73 7#a7 ,to establish a program for prescribing opioid overdose reversal drugs1 such as naloxone4 7#b7 ,to train and provide resources for health care providers and pharmacists on the prescribing of opioid overdose reversal drugs1 such as naloxone4 7#c7 ,to establish mechanisms and processes for tracking patients participating in the program described in paragraph 7#a7 and the health outcomes of such patients4 7#d7 ,to purchase opioid overdose reversal drugs1 such as naloxone1 for distribution under the program described in paragraph 7#a74 7#e7 ,to offset the co-pays and other cost sharing associated with opioid overdose reversal drugs1 such as naloxone1 to ensure that cost is not a limiting factor for eligible patients4 7#f7 ,to conduct community outreach1 in conjunction with community-based organizations1 designed to raise awareness of prescribing practices1 and the availability of opioid overdose reversal drugs1 such as naloxone4 7#g7 ,to establish protocols to connect patients who have experienced a drug overdose with appropriate treatment1 including medication assisted treatment and appropriate counseling and behavioral therapies4 7d7 ,evaluations by recipients ,as a condition of receipt of a grant under this section1 an eligible entity shall1 for each year for which the grant is received1 submit to the ,secretary of ,health and ,human ,services information on appropriate outcome measures specified by the ,secretary to assess the outcomes of the program funded by the grant1 including-- 7#a7 the number of prescribers trained2 7#b7 the number of prescribers who have co-prescribed an opioid overdose reversal drug1 such as naloxone1 to at least one patient2 7#c7 the total number of prescriptions written for opioid overdose reversal drugs1 such as naloxone2 7#d7 the percentage of patients at elevated risk who received a prescription for an opioid overdose reversal drug1 such as naloxone2 7#e7 the number of patients reporting use of an opioid overdose reversal drug1 such as naloxone2 and 7#f7 any other outcome measures that the ,secretary deems appropriate4 7e7 ,reports by ,secretary ,for each year of the grant program under this section1 the ,secretary of ,health and ,human ,services shall submit to the appropriate committees of the ,house of ,representatives and the ,senate a report aggregating the information received from the grant recipients for such year under subsection 7d7 and evaluating the outcomes achieved by the programs funded by grants made under this section4 7f7 ,providing information to prescribers in certain ,federal health care and medical facilities on best practices for prescribing opioid overdose reversal drugs 7#a7 ,in general ,not later than #ahj days after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services 7in this subsection referred to as the ,secretary7 may1 as appropriate1 provide information to prescribers within ,federally qualified health centers 7as defined in paragraph 7#d7 of section #ahfa7;aa7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7aa7771 and the health care facilities of the ,indian ,health ,service1 on best practices for prescribing opioid overdose reversal drugs1 such as naloxone1 for patients receiving chronic opioid therapy1 patients being treated for opioid use disorders1 and other patients that a provider identifies as having an elevated risk of overdose from heroin or prescription opioid therapies4 7#b7 ,not establishing a medical standard of care ,the information on best practices provided under this section shall not be construed as constituting or establishing a medical standard of care for prescribing opioid overdose reversal drugs1 such as naloxone1 for patients described in paragraph 7#a74 7#c7 ,no authorization of any additional appropriations ,the ,secretary shall carry out this subsection through funds otherwise appropriated and nothing in this subsection shall be construed as authorizing the appropriations of additional funds to carry out this subsection4 7#d7 ,elevated risk of overdose defined ,in this subsection1 the term elevated risk of overdose has the meaning given such term by the ,secretary1 which-- 7,a7 may be based on the criteria provided in the ,opioid ,overdose ,toolkit published by the ,substance ,abuse and ,mental ,health ,services ,administration 7,,samhsa72 and 7,b7 may include patients on a first course opioid treatment1 patients using extended-release and long-acting opioid analgesics1 and patients with a respiratory disease or other co-morbidities4 7g7 ,funding ,there is authorized to be appropriated #e1jjj1jjj to carry out this section 7other than subsection 7f77 for the period of fiscal years #bjag through #bjba1 of which #e1jjj1jjj shall be made available from amounts appropriated under section #aja7;a7 of the ,opioid ,use ,disorder ,treatment ,expansion and ,modernization ,act for fiscal year #bjag1 to remain available until expended4 #ajc4 ,partial fills of schedule ,,ii controlled substances 7a7 ,in general ,section #cji of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbi7 is amended by adding at the end the following3 7f7 ,partial fills of schedule ,,ii controlled substances 7#a7 ,partial fills 7,a7 ,in general ,a prescription for a controlled substance in schedule ,,ii may be partially filled if-- 7i7 it is not prohibited by ,state law2 7ii7 the prescription is written and filled in accordance with this ,act1 regulations prescribed by the ,attorney ,general1 and ,state law2 7iii7 the partial fill is requested by the patient or the practitioner that wrote the prescription2 and 7iv7 the total quantity dispensed in all partial fillings does not exceed the total quantity prescribed4 7,b7 ,other circumstances ,a prescription for a controlled substance in schedule ,,ii may be partially filled in accordance with section #acjf4ac of title #ba1 ,code of ,federal ,regulations 7as in effect on the date of enactment of the ,opioid ,abuse ,crisis ,act of #bjaf74 7#b7 ,remaining portions 7,a7 ,in general ,except as provided in subparagraph 7,b71 remaining portions of a partially filled prescription for a controlled substance in schedule ,,ii-- 7i7 may be filled2 and 7ii7 shall be filled not later than #cj days after the date on which the prescription is written4 7,b7 ,emergency situations ,in emergency situations1 as described in subsection 7a71 the remaining portions of a partially filled prescription for a controlled substance in schedule ,,ii-- 7i7 may be filled2 and 7ii7 shall be filled not later than #gb hours after the prescription is issued4 4 7b7 ,rule of construction ,nothing in this section shall be construed to affect the authority of the ,attorney ,general to allow a prescription for a controlled substance in schedule ,,iii1 ,,iv1 or ,v of section #bjb7;c7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hab7;c77 to be partially filled4 #ajd4 ,opioid use disorder treatment modernization 7a7 ,in general ,section #cjc7;g77#b7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;g77#b77 is amended-- 7#a7 in subparagraph 7,b71 by striking clauses 7i71 7ii71 and 7iii7 and inserting the following3 7i7 ,the practitioner is a qualifying practitioner 7as defined in subparagraph 7,g774 7ii7 ,with respect to patients to whom the practitioner will provide such drugs or combinations of drugs1 the practitioner has the capacity to provide directly1 by referral1 or in such other manner as determined by the ,secretary-- 7,i7 all schedule ,,iii1 ,,iv1 and ,v drugs1 as well as unscheduled medications approved by the ,food and ,drug ,administration1 for the treatment of opioid use disorder1 including such drugs and medications for maintenance1 detoxification1 overdose reversal1 and relapse prevention1 as available2 and 7,,ii7 appropriate counseling and other appropriate ancillary services4 7iii7 7,i7 ,the total number of such patients of the practitioner at any one time will not exceed the applicable number4 ,except as provided in subclauses 7,,ii7 and 7,,iii71 the applicable number is #cj4 7,,ii7 ,the applicable number is #ajj if1 not sooner than #a year after the date on which the practitioner submitted the initial notification1 the practitioner submits a second notification to the ,secretary of the need and intent of the practitioner to treat up to #ajj patients4 7,,iii7 ,the applicable number is #cjj if the practitioner is a qualifying physician meeting the requirement of subclause 7,,vi7 and1 not sooner than #a year after the date on which the physician submitted a second notification under subclause 7,,ii71 the practitioner submits a third notification to the ,secretary of the need and intent of the physician to treat up to #cjj patients4 7,,iv7 ,the ,secretary may by regulation change such total number4 7,v7 ,the ,secretary may exclude from the applicable number patients to whom such drugs or combinations of drugs are directly administered by the qualifying practitioner in the office setting4 7,,vi7 ,for purposes of subclause 7,,iii71 a qualifying physician meets the requirement of this subclause if the physician-- 7aa7 holds a special certification in addiction psychiatry or addiction medicine as described in clause 7ii7 from the ,american ,board of ,medical ,specialties1 the ,american ,board of ,addiction ,medicine1 the ,american ,osteopathic ,association1 the ,american ,society of ,addiction ,medicine1 or such other organization as the ,secretary determines to be appropriate for purposes of this subclause2 or 7bb7 has completed not fewer than #bd hours of training1 with respect to the treatment and management of opiate-dependent patients1 addressing the topics listed in subparagraph 7,g77ii77,,iv74 ,the ,secretary may review and update the requirements of this subclause4 7iv7 ,in the case of a third notification under clause 7iii77,,iii71 the qualifying physician maintains and implements a diversion control plan that contains specific measures to reduce the likelihood of the diversion of controlled substances prescribed by the physician for the treatment of opioid use disorder4 7v7 ,in the case of a third notification under clause 7iii77,,iii71 the qualifying physician obtains a written agreement from each patient1 including the patient's signature1 that the patient-- 7,i7 will receive an initial assessment and treatment plan and periodic assessments and treatment plans thereafter2 7,,ii7 will be subject to medication adherence and substance use monitoring2 7,,iii7 understands available treatment options1 including all drugs approved by the ,food and ,drug ,administration for the treatment of opioid use disorder1 including their potential risks and benefits2 and 7,,iv7 understands that receiving regular counseling services is critical to recovery4 7vi7 ,the practitioner will comply with the reporting requirements of subparagraph 7,d77i77,,iv74 2 7#b7 in subparagraph 7,d7-- 7,a7 in clause 7i71 by adding at the end the following3 7,,iv7 ,the practitioner reports to the ,secretary1 at such times and in such manner as specified by the ,secretary1 such information and assurances as the ,secretary determines necessary to assess whether the practitioner continues to meet the requirements for a waiver under this paragraph4 2 7,b7 in clause 7ii71 by striking ,upon receiving a notification under subparagraph 7,b7 and inserting ,upon receiving a determination from the ,secretary under clause 7iii7 finding that a practitioner meets all requirements for a waiver under subparagraph 7,b72 and 7,c7 in clause 7iii7-- 7i7 by inserting and shall forward such determination to the ,attorney ,general before the period at the end of the first sentence2 and 7ii7 by striking physician and inserting practitioner2 7#c7 in subparagraph 7,g7-- 7,a7 by amending clause 7ii77,,iv7 to read as follows3 7,,iv7 ,the physician has1 with respect to the treatment and management of opiate-dependent patients1 completed not less than eight hours of training 7through classroom situations1 seminars at professional society meetings1 electronic communications1 or otherwise7 that is provided by the ,american ,society of ,addiction ,medicine1 the ,american ,academy of ,addiction ,psychiatry1 the ,american ,medical ,association1 the ,american ,osteopathic ,association1 the ,american ,psychiatric ,association1 or any other organization that the ,secretary determines is appropriate for purposes of this subclause4 ,such training shall address-- 7aa7 opioid maintenance and detoxification2 7bb7 appropriate clinical use of all drugs approved by the ,food and ,drug ,administration for the treatment of opioid use disorder2 7cc7 initial and periodic patient assessments 7including substance use monitoring72 7dd7 individualized treatment planning2 overdose reversal2 relapse prevention2 7ee7 counseling and recovery support services2 7ff7 staffing roles and considerations2 7gg7 diversion control2 and 7hh7 other best practices1 as identified by the ,secretary4 2 and 7,b7 by adding at the end the following3 7iii7 ,the term qualifying practitioner means-- 7,i7 a qualifying physician1 as defined in clause 7ii72 or 7,,ii7 a qualifying other practitioner1 as defined in clause 7iv74 7iv7 ,the term qualifying other practitioner means a nurse practitioner or physician assistant who satisfies each of the following3 7,i7 ,the nurse practitioner or physician assistant is licensed under ,state law to prescribe schedule ,,iii1 ,,iv1 or ,v medications for the treatment of pain4 7,,ii7 ,the nurse practitioner or physician assistant satisfies #a or more of the following3 7aa7 ,has completed not fewer than #bd hours of initial training addressing each of the topics listed in clause 7ii77,,iv7 7through classroom situations1 seminars at professional society meetings1 electronic communications1 or otherwise7 provided by the ,american ,society of ,addiction ,medicine1 the ,american ,academy of ,addiction ,psychiatry1 the ,american ,medical ,association1 the ,american ,osteopathic ,association1 the ,american ,nurses ,credentialing ,center1 the ,american ,psychiatric ,association1 the ,american ,association of ,nurse ,practitioners1 the ,american ,academy of ,physician ,assistants1 or any other organization that the ,secretary determines is appropriate for purposes of this subclause4 7bb7 ,has such other training or experience as the ,secretary determines will demonstrate the ability of the nurse practitioner or physician assistant to treat and manage opiate-dependent patients4 7,,iii7 ,the nurse practitioner or physician assistant is supervised by or works in collaboration with a qualifying physician1 if the nurse practitioner or physician assistant is required by ,state law to prescribe medications for the treatment of opioid use disorder in collaboration with or under the supervision of a physician4 ,the ,secretary may review and update the requirements for being a qualifying other practitioner under this clause4 2 and 7#d7 in subparagraph 7,h7-- 7,a7 in clause 7i71 by inserting after subclause 7,,ii7 the following3 7,,iii7 ,such other elements of the requirements under this paragraph as the ,secretary determines necessary for purposes of implementing such requirements4 2 and 7,b7 by amending clause 7ii7 to read as follows3 7ii7 ,not later than one year after the date of enactment of the ,opioid ,use ,disorder ,treatment ,expansion and ,modernization ,act1 the ,secretary shall update the treatment improvement protocol containing best practice guidelines for the treatment of opioid-dependent patients in office-based settings4 ,the ,secretary shall update such protocol in consultation with experts in opioid use disorder research and treatment4 4 7b7 ,recommendation of revocation or suspension of registration in case of substantial noncompliance ,the ,secretary of ,health and ,human ,services may recommend to the ,attorney ,general that the registration of a practitioner be revoked or suspended if the ,secretary determines1 according to such criteria as the ,secretary establishes by regulation1 that a practitioner who is registered under section #cjc7;g77#b7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;g77#b77 is not in substantial compliance with the requirements of such section1 as amended by this ,act4 7c7 ,opioid defined ,section #ajb7ah7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb7ah77 is amended by inserting or opioid after ,the term opiate4 7d7 ,reports to ,congress 7#a7 ,in general ,not later than #b years after the date of enactment of this ,act and not less than over every #e years thereafter1 the ,secretary of ,health and ,human ,services1 in consultation with the ,drug ,enforcement ,administration and experts in opioid use disorder research and treatment1 shall-- 7,a7 perform a thorough review of the provision of opioid use disorder treatment services in the ,united ,states1 including services provided in opioid treatment programs and other specialty and nonspecialty settings2 and 7,b7 submit a report to the ,congress on the findings and conclusions of such review4 7#b7 ,contents ,each report under paragraph 7#a7 shall include an assessment of-- 7,a7 compliance with the requirements of section #cjc7;g77#b7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;g77#b771 as amended by this ,act2 7,b7 the measures taken by the ,secretary of ,health and ,human ,services to ensure such compliance2 7,c7 whether there is further need to increase or decrease the number of patients a waivered practitioner is permitted to treat1 as provided for by the amendment made by subsection 7a77#a72 7,d7 the extent to which1 and proportions with which1 the full range of ,food and ,drug ,administration-approved treatments for opioid use disorder are used in routine health care settings and specialty substance use disorder treatment settings2 7,e7 access to1 and use of1 counseling and recovery support services1 including the percentage of patients receiving such services2 7,f7 changes in ,state or local policies and legislation relating to opioid use disorder treatment2 7,g7 the use of prescription drug monitoring programs by practitioners who are permitted to dispense narcotic drugs to individuals pursuant to a waiver under section #cjc7;g77#b7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;g77#b772 7,h7 the findings resulting from inspections by the ,drug ,enforcement ,administration of practitioners described in subparagraph 7,g72 and 7,i7 the effectiveness of cross-agency collaboration between the ,department of ,health and ,human ,services and the ,drug ,enforcement ,administration for expanding effective opioid use disorder treatment4 #aje4 ,nurturing and supporting healthy babies 7a7 ,,gao report on neonatal abstinence syndrome 7,,nas7 7#a7 ,in general ,not later than one year after the date of the enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall submit to the ,committee on ,energy and ,commerce of the ,house of ,representatives and the ,committee on ,finance and the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate a report on neonatal abstinence syndrome 7in this section referred to as ,,nas7 in the ,united ,states4 7#b7 ,information to be included in report ,such report shall include information on the following3 7,a7 ,the prevalence of ,,nas in the ,united ,states1 including the proportion of children born in the ,united ,states with ,,nas who are eligible for medical assistance under ,state ,medicaid programs under title ,,xix of the ,social ,security ,act at birth and the costs associated with ,,nas through such programs4 7,b7 ,the services for which coverage is available under ,state ,medicaid programs for treatment of infants with ,,nas4 7,c7 ,the settings 7including inpatient1 outpatient1 hospital-based1 and other settings7 for the treatment of infants with ,,nas and the reimbursement methodologies and costs associated with such treatment in such settings4 7,d7 ,the prevalence of utilization of various care settings under ,state ,medicaid programs for treatment of infants with ,,nas and any ,federal barriers to treating such infants under such programs1 particularly in non-hospital-based settings4 7#c7 ,recommendations ,such report also shall include such recommendations as the ,comptroller ,general determines appropriate for improvements that will ensure access to treatment for infants with ,,nas under ,state ,medicaid programs4 7b7 ,excluding abuse-,deterrent formulations of prescription drugs from the ,medicaid additional rebate requirement for new formulations of prescription drugs 7#a7 ,in general ,the last sentence of section #aibg7;c77#b77;,c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acifr-#h7;c77#b77;,c77 is amended by inserting before the period at the end the following3 1 but does not include an abuse-deterrent formulation of the drug 7as determined by the ,secretary71 regardless of whether such abuse-deterrent formulation is an extended release formulation4 7#b7 ,effective date ,the amendment made by paragraph 7#a7 shall apply to drugs that are paid for by a ,state in calendar quarters beginning on or after the date of the enactment of this ,act4 7c7 ,limiting disclosure of predictive modeling and other analytics technologies ,to identify and prevent waste1 fraud1 and abuse 7#a7 ,in general ,title ,,xi of the ,social ,security ,act is amended by inserting after section #aabh;,j 7#db ,u4,s4,c4 #acbj;a-#gk7 the following new section3 #aabh,k4 ,disclosure of predictive modeling and other analytics technologies to identify and prevent waste1 fraud1 and abuse 7a7 ,reference to predictive modeling technologies requirements ,for provisions relating to the use of predictive modeling and other analytics technologies to identify and prevent waste1 fraud1 and abuse with respect to the ,medicare program under title ,,xviii1 the ,medicaid program under title ,,xix1 and the ,children's ,health ,insurance ,program under title ,,xxi1 see section #dbda of the ,small ,business ,jobs ,act of #bjaj 7#db ,u4,s4,c4 #acbj;a-#gm74 7b7 ,limiting disclosure of predictive modeling technologies ,in implementing such provisions under such section #dbda with respect to covered algorithms 7as defined in subsection 7c771 the following shall apply3 7#a7 ,nonapplication of ,,foia ,the covered algorithms used or developed for purposes of such section 7including by the ,secretary or a ,state 7or an entity operating under a contract with a ,state77 shall be exempt from disclosure under section #eeb7;b77#c7 of title #e1 ,united ,states ,code4 7#b7 ,limitation with respect to use and disclosure of information by ,state agencies 7,a7 ,in general ,a ,state agency may not use or disclose covered algorithms used or developed for purposes of such section except for purposes of administering the ,state plan 7or a waiver of the plan7 under the ,medicaid program under title ,,xix or the ,state child health plan 7or a waiver of the plan7 under the ,children's ,health ,insurance ,program under title ,,xxi1 including by enabling an entity operating under a contract with a ,state to assist the ,state to identify or prevent waste1 fraud and abuse with respect to such programs4 7,b7 ,information security ,a ,state agency shall have in effect data security and control policies that the ,secretary finds adequate to ensure the security of covered algorithms used or developed for purposes of such section #dbda and to ensure that access to such information is restricted to authorized persons for purposes of authorized uses and disclosures described in subparagraph 7,a74 7,c7 ,procedural requirements ,state agencies to which information is disclosed pursuant to such section #dbda shall adhere to uniform procedures established by the ,secretary4 7c7 ,covered algorithm defined ,in this section1 the term covered algorithm-- 7#a7 means a predictive modeling or other analytics technology1 as used for purposes of section #dbda7;a7 of the ,small ,business ,jobs ,act of #bjaj 7#db ,u4,s4,c4 #acbj;a-#gm7a77 to identify and prevent waste1 fraud1 and abuse with respect to the ,medicare program under title ,,xviii1 the ,medicaid program under title ,,xix1 and the ,children's ,health ,insurance ,program under title ,,xxi2 and 7#b7 includes the mathematical expressions utilized in the application of such technology and the means by which such technology is developed4 4 7#b7 ,conforming amendments 7,a7 ,medicaid ,state plan requirement ,section #aijb7;a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acif;a7a77 is amended-- 7i7 in paragraph 7#hj71 by striking and at the end2 7ii7 in paragraph 7#ha71 by striking the period at the end and inserting 2 and2 and 7iii7 by inserting after paragraph 7#ha7 the following new paragraph3 7#hb7 provide that the ,state agency responsible for administering the ,state plan under this title provides assurances to the ,secretary that the ,state agency is in compliance with subparagraphs 7,a71 7,b71 and 7,c7 of section #aabh,k7b77#b74 4 7,b7 ,state child health plan requirement ,section #bajb7;a77#g7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acig;bb7a77#g77 is amended-- 7i7 in subparagraph 7,a71 by striking 1 and at the end and inserting a semicolon2 7ii7 in subparagraph 7,b71 by striking the period at the end and inserting 2 and2 and 7iii7 by adding at the end the following new subparagraph3 7,c7 to ensure that the ,state agency involved is in compliance with subparagraphs 7,a71 7,b71 and 7,c7 of section #aabh,k7b77#b74 4 7d7 ,medicaid ,improvement ,fund ,section #aida7;b77#a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acifw-#a7;b77#a77 is amended to read as follows3 7#a7 ,in general ,there shall be available to the ,fund1 for expenditures from the ,fund for fiscal year #bjba and thereafter1 #e1jjj1jjj4 4 #ajf4 ,improving treatment for pregnant and postpartum women 7a7 ,reauthorization of residential treatment programs for pregnant and postpartum women ,section #ejh of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bij;bb-#a7 is amended-- 7#a7 in subsection 7p71 in the first sentence1 by inserting 7other than subsection 7r77 after section2 and 7#b7 in subsection 7r71 by striking such sums and all that follows through #bjjc and inserting #af1ijj1jjj for each of fiscal years #bjag through #bjba4 7b7 ,pilot program grants for ,state substance abuse agencies 7#a7 ,in general ,section #ejh of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bij;bb-#a7 is amended-- 7,a7 by redesignating subsection 7r71 as amended by subsection 7a71 as subsection 7s72 and 7,b7 by inserting after subsection 7q7 the following new subsection3 7r7 ,pilot program for ,state substance abuse agencies 7#a7 ,in general ,from amounts made available under subsection 7s71 the ,director of the ,center for ,substance ,abuse ,treatment shall carry out a pilot program under which competitive grants are made by the ,director to ,state substance abuse agencies to-- 7,a7 enhance flexibility in the use of funds designed to support family-based services for pregnant and postpartum women with a primary diagnosis of a substance use disorder1 including opioid use disorders2 7,b7 help ,state substance abuse agencies address identified gaps in services furnished to such women along the continuum of care1 including services provided to women in nonresidential based settings2 and 7,c7 promote a coordinated1 effective1 and efficient ,state system managed by ,state substance abuse agencies by encouraging new approaches and models of service delivery4 7#b7 ,requirements ,in carrying out the pilot program under this subsection1 the ,director shall-- 7,a7 require ,state substance abuse agencies to submit to the ,director applications1 in such form and manner and containing such information as specified by the ,director1 to be eligible to receive a grant under the program2 7,b7 identify1 based on such submitted applications1 ,state substance abuse agencies that are eligible for such grants2 7,c7 require services proposed to be furnished through such a grant to support family-based treatment and other services for pregnant and postpartum women with a primary diagnosis of a substance use disorder1 including opioid use disorders2 7,d7 not require that services furnished through such a grant be provided solely to women that reside in facilities2 7,e7 not require that grant recipients under the program make available through use of the grant all services described in subsection 7d72 and 7,f7 consider not applying requirements described in paragraphs 7#a7 and 7#b7 of subsection 7f7 to applicants1 depending on the circumstances of the applicant4 7#c7 ,required services 7,a7 ,in general ,the ,director shall specify a minimum set of services required to be made available to eligible women through a grant awarded under the pilot program under this subsection4 ,such minimum set-- 7i7 shall include requirements described in subsection 7c7 and be based on the recommendations submitted under subparagraph 7,b72 and 7ii7 may be selected from among the services described in subsection 7d7 and include other services as appropriate4 7,b7 ,stakeholder input ,the ,director shall convene and solicit recommendations from stakeholders1 including ,state substance abuse agencies1 health care providers1 persons in recovery from substance abuse1 and other appropriate individuals1 for the minimum set of services described in subparagraph 7,a74 7#d7 ,duration ,the pilot program under this subsection shall not exceed #e years4 7#e7 ,evaluation and ,report to ,congress ,the ,director of the ,center for ,behavioral ,health ,statistics and ,quality shall fund an evaluation of the pilot program at the conclusion of the first grant cycle funded by the pilot program4 ,the ,director of the ,center for ,behavioral ,health ,statistics and ,quality1 in coordination with the ,director of the ,center for ,substance ,abuse ,treatment shall submit to the relevant committees of jurisdiction of the ,house of ,representatives and the ,senate a report on such evaluation4 ,the report shall include at a minimum outcomes information from the pilot program1 including any resulting reductions in the use of alcohol and other drugs2 engagement in treatment services2 retention in the appropriate level and duration of services2 increased access to the use of medications approved by the ,food and ,drug ,administration for the treatment of substance use disorders in combination with counseling2 and other appropriate measures4 7#f7 ,state substance abuse agencies defined ,for purposes of this subsection1 the term ,state substance abuse agency means1 with respect to a ,state1 the agency in such ,state that manages the ,substance ,abuse ,prevention and ,treatment ,block ,grant under part ,b of title ,,xix4 4 7#b7 ,funding ,subsection 7s7 of section #ejh of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bij;bb-#a71 as amended by subsection 7a7 and redesignated by paragraph 7#a71 is further amended by adding at the end the following new sentence3 ,of the amounts made available for a year pursuant to the previous sentence to carry out this section1 not more than #be percent of such amounts shall be made available for such year to carry out subsection 7r71 other than paragraph 7#e7 of such subsection4 ,notwithstanding the preceding sentence1 no funds shall be made available to carry out subsection 7r7 for a fiscal year unless the amount made available to carry out this section for such fiscal year is more than the amount made available to carry out this section for fiscal year #bjaf44 7c7 ,cut-,go ,compliance ,subsection 7f7 of section #cai;,d of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;d-#d7 is amended by striking through #bjah and inserting through #bjaf1 #acc1cjj1jjj for fiscal year #bjag1 and #ach1cjj1jjj for fiscal year #bjah4 #ajg4 ,assisting veterans with military emergency medical training to meet requirements for becoming civilian emergency medical technicians ,part ,b of title ,,iii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdc et seq47 is amended by inserting after section #cad the following3 #cae4 ,assisting veterans with military emergency medical training to meet requirements for becoming civilian emergency medical technicians 7a7 ,program ,the ,secretary shall establish a program consisting of awarding demonstration grants to ,states to streamline ,state requirements and procedures in order to assist veterans who completed military emergency medical technician training while serving in the ,armed ,forces of the ,united ,states to meet certification1 licensure1 and other requirements applicable to becoming an emergency medical technician in the ,state4 7b7 ,use of funds ,amounts received as a demonstration grant under this section shall be used to prepare and implement a plan to streamline ,state requirements and procedures as described in subsection 7a71 including by-- 7#a7 determining the extent to which the requirements for the education1 training1 and skill level of emergency medical technicians in the ,state are equivalent to requirements for the education1 training1 and skill level of military emergency medical technicians2 and 7#b7 identifying methods1 such as waivers1 for military emergency medical technicians to forgo or meet any such equivalent ,state requirements4 7c7 ,eligibility ,to be eligible for a grant under this section1 a ,state shall demonstrate that the ,state has a shortage of emergency medical technicians4 7d7 ,report ,the ,secretary shall submit to the ,congress an annual report on the program under this section4 7e7 ,funding ,no additional funds are authorized to be appropriated for the purpose of carrying out this section4 ,this section shall be carried out using amounts otherwise available for such purpose4 4 #ajh4 ,information materials and resources to prevent addiction related to youth sports injuries 7a7 ,technical clarification ,effective as if included in the enactment of the ,children's ,health ,act of #bjjj 7,public ,law #ajf-caj71 section #cdje7;a7 of such ,act 7#aad ,stat4 #abba7 is amended by striking ,part ,e of title ,,iii and inserting ,part ,e of title ,,iii of the ,public ,health ,service ,act4 7b7 ,amendment ,title ,,iii of the ,public ,health ,service ,act is amended by inserting after part ,d of such title 7#db ,u4,s4,c4 #bed;b et seq47 the following new part ,e3 ,e ,opioid ,use ,disorder #cda4 ,information materials and resources to prevent addiction related to youth sports injuries 7a7 ,report ,the ,secretary shall-- 7#a7 not later than #bd months after the date of the enactment of this section1 make publicly available a report determining the extent to which informational materials and resources described in subsection 7b7 are available to teenagers and adolescents who play youth sports1 families of such teenagers and adolescents1 nurses1 youth sports groups1 and relevant health care provider groups2 and 7#b7 for purposes of educating and preventing addiction in teenagers and adolescents who are injured playing youth sports and are subsequently prescribed an opioid1 not later than #ab months after such report is made publicly available and taking into consideration the findings of such report1 develop and1 in coordination with youth sports groups1 disseminate informational materials and resources described in subsection 7b7 for teenagers and adolescents who play youth sports1 families of such teenagers and adolescents1 nurses1 youth sports groups1 and relevant health care provider groups4 7b7 ,materials and resources described ,for purposes of this section1 the informational materials and resources described in this subsection are informational materials and resources with respect to youth sports injuries for which opioids are potentially prescribed and subsequently potentially lead to addiction1 including materials and resources focused on the dangers of opioid use and misuse1 treatment options for such injuries that do not involve the use of opioids1 and how to seek treatment for addiction4 7c7 ,no additional funds ,no additional funds are authorized to be appropriated for the purpose of carrying out this section4 ,this section shall be carried out using amounts otherwise available for such purpose4 4 #aji4 ,lali's ,law 7a7 ,opioid overdose reversal medication access and education grant program ,part ,e of title ,,iii of the ,public ,health ,service ,act1 as added by section #aji1 is amended by adding at the end the following #cdb4 ,opioid overdose reversal medication access and education grant programs 7a7 ,grants to ,states ,the ,secretary may make grants to ,states for-- 7#a7 developing standing orders for pharmacies regarding opioid overdose reversal medication2 7#b7 encouraging pharmacies to dispense opioid overdose reversal medication pursuant to a standing order2 7#c7 implementing best practices for persons authorized to prescribe medication regarding-- 7,a7 prescribing opioids for the treatment of chronic pain2 7,b7 co-prescribing opioid overdose reversal medication with opioids2 and 7,c7 discussing the purpose and administration of opioid overdose reversal medication with patients2 7#d7 developing or adapting training materials and methods for persons authorized to prescribe or dispense medication to use in educating the public regarding-- 7,a7 when and how to administer opioid overdose reversal medication2 and 7,b7 steps to be taken after administering opioid overdose reversal medication2 and 7#e7 educating the public regarding-- 7,a7 the public health benefits of opioid overdose reversal medication2 and 7,b7 the availability of opioid overdose reversal medication without a person-specific prescription4 7b7 ,certain requirement ,a grant may be made under this section only if the ,state involved has authorized standing orders regarding opioid overdose reversal medication4 7c7 ,preference in making grants ,in making grants under this section1 the ,secretary shall give preference to ,states that-- 7#a7 have not issued standing orders regarding opioid overdose reversal medication2 7#b7 authorize standing orders that permit community-based organizations1 substance abuse programs1 or other nonprofit entities to acquire1 dispense1 or administer opioid overdose reversal medication2 7#c7 authorize standing orders that permit police1 fire1 or emergency medical services agencies to acquire and administer opioid overdose reversal medication2 7#d7 have a higher per capita rate of opioid overdoses than other applicant ,states2 or 7#e7 meet any other criteria deemed appropriate by the ,secretary4 7d7 ,grant terms 7#a7 ,number ,a ,state may not receive more than #a grant under this section4 7#b7 ,period ,a grant under this section shall be for a period of #c years4 7#c7 ,amount ,a grant under this section may not exceed #ejj1jjj4 7#d7 ,limitation ,a ,state may use not more than #bj percent of a grant under this section for educating the public pursuant to subsection 7a77#e74 7e7 ,applications ,to be eligible to receive a grant under this section1 a ,state shall submit an application to the ,secretary in such form and manner and containing such information as the ,secretary may require1 including detailed proposed expenditures of grant funds4 7f7 ,reporting ,not later than #c months after the ,secretary disburses the first grant payment to any ,state under this section and every #f months thereafter for #c years1 such ,state shall submit a report to the ,secretary that includes the following3 7#a7 ,the name and ,,zip ,code of each pharmacy in the ,state that dispenses opioid overdose reversal medication under a standing order4 7#b7 ,the total number of opioid overdose reversal medication doses dispensed by each such pharmacy1 specifying how many were dispensed with or without a person-specific prescription4 7#c7 ,the number of pharmacists in the ,state who have participated in training pursuant to subsection 7a77#d74 7g7 ,definitions ,in this section3 7#a7 ,opioid overdose reversal medication ,the term opioid overdose reversal medication means any drug1 including naloxone1 that-- 7,a7 blocks opioids from attaching to1 but does not itself activate1 opioid receptors2 or 7,b7 inhibits the effects of opioids on opioid receptors4 7#b7 ,standing order ,the term standing order means a document prepared by a person authorized to prescribe medication that permits another person to acquire1 dispense1 or administer medication without a person-specific prescription4 7h7 ,authorization of appropriations 7#a7 ,in general ,to carry out this section1 there is authorized to be appropriated #e1jjj1jjj for the period of fiscal years #bjag through #bjai4 7#b7 ,administrative costs ,not more than #c percent of the amounts made available to carry out this section may be used by the ,secretary for administrative expenses of carrying out this section4 4 7b7 ,cut-,go ,compliance ,subsection 7f7 of section #cai;,d of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;d-#d7 is amended by inserting before the period at the end the following3 7except such dollar amount shall be reduced by #e1jjj1jjj for fiscal year #bjag74 #aaj4 ,opioid review modernization 7a7 ,,fda opioid action plan ,chapter ,v of the ,federal ,food1 ,drug1 and ,cosmetic ,act is amended by inserting after section #efi of such ,act 7#ba ,u4,s4,c4 #cej;bbb-#h7 the following3 #efi-a4 ,opioid action plan 7a7 ,new drug application 7#a7 ,in general ,subject to paragraph 7#b71 prior to the approval pursuant to an application under section #eje7;b7 of a new drug that is an opioid and does not have abuse-deterrent properties1 the ,secretary shall refer the application to an advisory committee of the ,food and ,drug ,administration to seek recommendations from such advisory committee4 7#b7 ,public health exemption ,a referral to an advisory committee under paragraph 7#a7 is not required with respect to a new drug if the ,secretary-- 7,a7 finds that such a referral is not in the interest of protecting and promoting public health2 7,b7 finds that such a referral is not necessary based on a review of the relevant scientific information2 and 7,c7 submits a notice containing the rationale for such findings to the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate and the ,committee on ,energy and ,commerce of the ,house of ,representatives4 7b7 ,pediatric opioid labeling ,the ,secretary shall convene the ,pediatric ,advisory ,committee of the ,food and ,drug ,administration to seek recommendations from such ,committee regarding a framework for the inclusion of information in the labeling of drugs that are opioids relating to the use of such drugs in pediatric populations before the ,secretary approves any labeling or change to labeling for any drug that is an opioid intended for use in a pediatric population4 7c7 ,sunset ,the requirements of subsections 7a7 and 7b7 shall cease to be effective on ,october #a1 #bjbb4 4 7b7 ,prescriber education ,not later than #a year after the date of the enactment of this ,act1 the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 as part of the ,food and ,drug ,administration's evaluation of the ,extended-,release_/,long-,acting ,opioid ,analgesics ,risk ,evaluation and ,mitigation ,strategy1 and in consultation with relevant stakeholders1 shall develop recommendations regarding education programs for prescribers of opioids pursuant to section #eje-a of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee-a71 including recommendations on-- 7#a7 which prescribers should participate in such programs2 and 7#b7 how often participation in such programs is necessary4 7c7 ,guidance on evaluating the abuse deterrence of generic solid oral opioid drug products ,not later than #b years after the end of the period for public comment on the draft guidance entitled ,general ,principals for ,evaluating the ,abuse ,deterrence of ,generic ,solid ,oral ,opioid ,drug ,products issued by the ,center for ,drug ,evaluation and ,research of the ,food and ,drug ,administration in ,march #bjaf1 the ,commissioner of ,food and ,drugs shall publish in the ,federal ,register a final version of such guidance4 #aaa4 ,study on treatment infrastructure ,not later than #bd months after the date of enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall initiate an evaluation1 and submit to ,congress a report1 of the inpatient and outpatient treatment capacity1 availability1 and needs of the ,united ,states1 which shall include1 to the extent data are available-- 7#a7 the capacity of acute residential or inpatient detoxification programs2 7#b7 the capacity of inpatient clinical stabilization programs1 transitional residential support services1 and residential rehabilitation programs2 7#c7 the capacity of demographic specific residential or inpatient treatment programs1 such as those designed for pregnant women or adolescents2 7#d7 geographical differences of the availability of residential and outpatient treatment and recovery options for substance use disorders across the continuum of care2 7#e7 the availability of residential and outpatient treatment programs that offer treatment options based on reliable scientific evidence of efficacy for the treatment of substance use disorders1 including the use of ,food and ,drug ,administration-approved medicines and evidence-based nonpharmacological therapies2 7#f7 the number of patients in residential and specialty outpatient treatment services for substance use disorders2 7#g7 an assessment of the need for residential and outpatient treatment for substance use disorders across the continuum of care2 7#h7 the availability of residential and outpatient treatment programs to ,american ,indians and ,alaska ,natives through an ,indian health program 7as defined by section #d of the ,indian ,health ,care ,improvement ,act 7#be ,u4,s4,c4 #afjc772 and 7#i7 the barriers 7including technological barriers7 at the ,federal1 ,state1 and local levels to real-time reporting of de-identified information on drug overdoses and ways to overcome such barriers4 #aab4 ,national youth recovery initiative ,part ,,ii of title ,i of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh 7#db ,u4,s4,c4 #cgig;cc et seq47 is amended by adding at the end the following3 #biii;,a4 ,national youth recovery initiative 7a7 ,definitions ,in this section3 7#a7 ,eligible entity ,the term eligible entity means-- 7,a7 a high school that has been accredited as a recovery high school by the ,association of ,recovery ,schools2 7,b7 an accredited high school that is seeking to establish or expand recovery support services2 7,c7 an institution of higher education2 7,d7 a recovery program at a nonprofit collegiate institution2 or 7,e7 a nonprofit organization4 7#b7 ,institution of higher education ,the term institution of higher education has the meaning given the term in section #aja of the ,higher ,education ,act of #aife 7#bj ,u4,s4,c4 #ajja74 7#c7 ,recovery program ,the term recovery program-- 7,a7 means a program to help individuals who are recovering from substance use disorders to initiate1 stabilize1 and maintain healthy and productive lives in the community2 and 7,b7 includes peer-to-peer support and communal activities to build recovery skills and supportive social networks4 7b7 ,grants authorized ,the ,secretary of ,health and ,human ,services1 in coordination with the ,secretary of ,education1 may award grants to eligible entities to enable the entities to-- 7#a7 provide substance use disorder recovery support services to young people in high school and enrolled in institutions of higher education2 7#b7 help build communities of support for young people in recovery through a spectrum of activities such as counseling and health- and wellness-oriented social activities2 and 7#c7 encourage initiatives designed to help young people achieve and sustain recovery from substance use disorders4 7c7 ,use of funds ,grants awarded under subsection 7b7 may be used for activities to develop1 support1 and maintain youth recovery support services1 including-- 7#a7 the development and maintenance of a dedicated physical space for recovery programs2 7#b7 dedicated staff for the provision of recovery programs2 7#c7 health- and wellness-oriented social activities and community engagement2 7#d7 establishment of recovery high schools2 7#e7 coordination of recovery programs with-- 7,a7 substance use disorder treatment programs and systems2 7,b7 providers of mental health services2 7,c7 primary care providers and physicians2 7,d7 the criminal justice system1 including the juvenile justice system2 7,e7 employers2 7,f7 housing services2 7,g7 child welfare services2 7,h7 high schools and institutions of higher education2 and 7,i7 other programs or services related to the welfare of an individual in recovery from a substance use disorder2 7#f7 the development of peer-to-peer support programs or services2 and 7#g7 additional activities that help youths and young adults to achieve recovery from substance use disorders4 7d7 ,funding ,there is authorized to be appropriated #e1jjj1jjj to carry out this section for each of fiscal years #bjag through #bjba1 of which #e1jjj1jjj shall be made available from amounts appropriated under section #aja7;a7 of the ,opioid ,use ,disorder ,treatment ,expansion and ,modernization ,act for fiscal year #bjag1 to remain available until expended4 4 #aac4 ,building communities of recovery ,part ,,ii of title ,i of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh 7#db ,u4,s4,c4 #cgig;cc et seq471 as amended by section #aac1 is amended by adding at the end the following3 #biii;,b4 ,building communities of recovery 7a7 ,definition ,in this section1 the term recovery community organization means an independent nonprofit organization that-- 7#a7 mobilizes resources within and outside of the recovery community to increase the prevalence and quality of long-term recovery from substance use disorders2 and 7#b7 is wholly or principally governed by people in recovery for substance use disorders who reflect the community served4 7b7 ,grants authorized ,the ,secretary of ,health and ,human ,services may award grants to recovery community organizations to enable such organizations to develop1 expand1 and enhance recovery services4 7c7 ,federal share ,the ,federal share of the costs of a program funded by a grant under this section may not exceed #ej percent4 7d7 ,use of funds ,grants awarded under subsection 7b7-- 7#a7 shall be used to develop1 expand1 and enhance community and statewide recovery support services2 and 7#b7 may be used to-- 7,a7 advocate for individuals in recovery from substance use disorders2 7,b7 build connections between recovery networks1 between recovery community organizations1 and with other recovery support services1 including-- 7i7 substance use disorder treatment programs and systems2 7ii7 providers of mental health services2 7iii7 primary care providers and physicians2 7iv7 the criminal justice system2 7v7 employers2 7vi7 housing services2 7vii7 child welfare agencies2 and 7viii7 other recovery support services that facilitate recovery from substance use disorders2 7,c7 reduce the stigma associated with substance use disorders2 7,d7 conduct public education and outreach on issues relating to substance use disorders and recovery1 including-- 7i7 how to identify the signs of addiction2 7ii7 the resources that are available to individuals struggling with addiction and families who have a family member struggling with or being treated for addiction1 including programs that mentor and provide support services to children2 7iii7 the resources that are available to help support individuals in recovery2 and 7iv7 information on the medical consequences of substance use disorders1 including neonatal abstinence syndrome and potential infection with human immunodeficiency virus and viral hepatitis2 and 7,e7 carry out other activities that strengthen the network of community support for individuals in recovery4 7e7 ,funding ,of the amounts appropriated under section #aja7;a7 of the ,opioid ,use ,disorder ,treatment ,expansion and ,modernization ,act for fiscal year #bjag1 #be1jjj1jjj shall be made available to carry out this section1 to remain available until expended 4 ,,ii ,comprehensive ,opioid ,abuse ,reduction #bja4 ,comprehensive opioid abuse grant program 7a7 ,in general ,title ,i of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh 7#db ,u4,s4,c4 #cgaa et seq47 is amended by adding at the end the following3 ,,ll ,,comprehensive ,,opioid ,,abuse ,,grant ,,program #cjba4 ,description 7a7 ,grants authorized ,from amounts made available to carry out this part1 the ,attorney ,general may make grants to ,states1 units of local government1 and ,indian tribes1 for use by the ,state1 unit of local government1 or ,indian tribe to provide services primarily relating to opioid abuse1 including for any one or more of the following3 7#a7 ,developing1 implementing1 or expanding a treatment alternative to incarceration program1 which may include-- 7,a7 pre-booking or post-booking components1 which may include the activities described in part ,,hh of this title2 7,b7 training for criminal justice agency personnel on substance use disorders and co-occurring mental illness and substance use disorders2 7,c7 a mental health court1 including the activities described in part ,v of this title2 7,d7 a drug court1 including the activities described in part ,,ee of this title2 and 7,e7 a veterans treatment court program1 including the activities described in subsection 7i7 of section #biia of this title4 7#b7 ,in the case of a ,state1 facilitating or enhancing planning and collaboration between ,state criminal justice agencies and ,state substance abuse systems in order to more efficiently and effectively carry out programs described in paragraph 7#a7 that address problems related to opioid abuse4 7#c7 ,providing training and resources for first responders on carrying and administering an opioid overdose reversal drug or device approved by the ,food and ,drug ,administration1 and purchasing such a drug or device for first responders who have received such training to carry and administer4 7#d7 ,investigative purposes to locate or investigate illicit activities related to the unlawful distribution of opioids4 7#e7 ,developing1 implementing1 or expanding a medication-assisted treatment program used or operated by a criminal justice agency1 which may include training criminal justice agency personnel on medication-assisted treatment1 and carrying out the activities described in part ,s of this title4 7#f7 ,in the case of a ,state1 developing1 implementing1 or expanding a prescription drug monitoring program to collect and analyze data related to the prescribing of schedule ,,ii1 ,,iii1 and ,,iv controlled substances through a centralized database administered by an authorized ,state agency1 which includes tracking the dispensation of such substances1 and providing for data sharing with other ,states4 7#g7 ,developing1 implementing1 or expanding a program to prevent and address opioid abuse by juveniles4 7#h7 ,developing1 implementing1 or expanding an integrated and comprehensive opioid abuse response program4 7b7 ,contracts and subawards ,a ,state1 unit of local government1 or ,indian tribe may1 in using a grant under this subpart for purposes authorized by subsection 7a71 use all or a portion of that grant to contract with or make one or more subawards to one or more-- 7#a7 local or regional organizations that are private and nonprofit1 including faith-based organizations2 7#b7 units of local government2 or 7#c7 tribal organizations4 7c7 ,program assessment component2 waiver 7#a7 ,program assessment component ,each program funded under this subpart shall contain a program assessment component1 developed pursuant to guidelines established by the ,attorney ,general1 in coordination with the ,national ,institute of ,justice4 7#b7 ,waiver ,the ,attorney ,general may waive the requirement of paragraph 7#a7 with respect to a program if1 in the opinion of the ,attorney ,general1 the program is not of sufficient size to justify a full program assessment4 7d7 ,administrative costs ,not more than #aj percent of a grant made under this subpart may be used for costs incurred to administer such grant4 7e7 ,period ,the period of a grant made under this part may not be longer than #d years1 except that renewals and extensions beyond that period may be granted at the discretion of the ,attorney ,general4 #cjbb4 ,applications ,to request a grant under this part1 the chief executive officer of a ,state1 unit of local government1 or ,indian tribe shall submit an application to the ,attorney ,general at such time and in such form as the ,attorney ,general may require4 ,such application shall include the following3 7#a7 ,a certification that ,federal funds made available under this subpart will not be used to supplant ,state1 local1 or tribal funds1 but will be used to increase the amounts of such funds that would1 in the absence of ,federal funds1 be made available for the activities described in section #cjba7;a74 7#b7 ,an assurance that1 for each fiscal year covered by an application1 the applicant shall maintain and report such data1 records1 and information 7programmatic and financial7 as the ,attorney ,general may reasonably require4 7#c7 ,a certification1 made in a form acceptable to the ,attorney ,general and executed by the chief executive officer of the applicant 7or by another officer of the applicant1 if qualified under regulations promulgated by the ,attorney ,general71 that-- 7,a7 the programs to be funded by the grant meet all the requirements of this part2 7,b7 all the information contained in the application is correct2 7,c7 there has been appropriate coordination with affected agencies2 and 7,d7 the applicant will comply with all provisions of this part and all other applicable ,federal laws4 7#d7 ,an assurance that the applicant will work with the ,drug ,enforcement ,administration to develop an integrated and comprehensive strategy to address opioid abuse4 #cjbc4 ,review of applications ,the ,attorney ,general shall not finally disapprove any application 7or any amendment to that application7 submitted under this part without first affording the applicant reasonable notice of any deficiencies in the application and opportunity for correction and reconsideration4 #cjbd4 ,geographic diversity ,the ,attorney ,general shall ensure equitable geographic distribution of grants under this part and take into consideration the needs of underserved populations1 including rural and tribal communities4 #cjbe4 ,definitions ,in this part3 7#a7 ,the term first responder includes a firefighter1 law enforcement officer1 paramedic1 emergency medical technician1 or other individual 7including an employee of a legally organized and recognized volunteer organization1 whether compensated or not71 who1 in the course of professional duties1 responds to fire1 medical1 hazardous material1 or other similar emergencies4 7#b7 ,the term medication-assisted treatment means the use of medications approved by the ,food and ,drug ,administration for the treatment of opioid abuse4 7#c7 ,the term opioid means any drug1 including heroin1 having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having such addiction-forming or addiction-sustaining liability4 7#d7 ,the term schedule ,,ii1 ,,iii1 or ,,iv controlled substance means a controlled substance that is listed on schedule ,,ii1 schedule ,,iii1 or schedule ,,iv of section #bjb7;c7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hab7;c774 7#e7 ,the terms drug and device have the meanings given those terms in section #bja of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cba74 7#f7 ,the term criminal justice agency means a ,state1 local1 or tribal-- 7,a7 court2 7,b7 prison2 7,c7 jail2 7,d7 law enforcement agency2 or 7,e7 other agency that performs the administration of criminal justice1 including prosecution1 pretrial services1 and community supervision4 7#g7 ,the term tribal organization has the meaning given that term in section #d of the ,indian ,self-,determination and ,education ,assistance ,act 7#be ,u4,s4,c4 #dej;b74 4 7b7 ,funding ,there is authorized to be appropriated #fe1jjj1jjj to carry out this section1 section #bjc1 and section #bjd 7including the amendments made by such sections7 for the period of fiscal years #bjag through #bjba1 of which #fe1jjj1jjj shall be made available from amounts appropriated under section #aja7;a7 of the ,opioid ,use ,disorder ,treatment ,expansion and ,modernization ,act for fiscal year #bjag1 to remain available until expended4 #bjb4 ,audit and accountability of grantees 7a7 ,definitions ,in this section-- 7#a7 the term covered grant program means a grant program operated by the ,department of ,justice2 7#b7 the term covered grantee means a recipient of a grant from a covered grant program2 7#c7 the term nonprofit1 when used with respect to an organization1 means an organization that is described in section #eja7;c77#c7 of the ,internal ,revenue ,code of #aihf1 and is exempt from taxation under section #eja7;a7 of such ,code2 and 7#d7 the term unresolved audit finding means an audit report finding in a final audit report of the ,inspector ,general of the ,department of ,justice that a covered grantee has used grant funds awarded to that grantee under a covered grant program for an unauthorized expenditure or otherwise unallowable cost that is not closed or resolved during a #ab-month period prior to the date on which the final audit report is issued4 7b7 ,audit requirement ,beginning in fiscal year #bjaf1 and annually thereafter1 the ,inspector ,general of the ,department of ,justice shall conduct audits of covered grantees to prevent waste1 fraud1 and abuse of funds awarded under covered grant programs4 ,the ,inspector ,general shall determine the appropriate number of covered grantees to be audited each year4 7c7 ,mandatory exclusion ,a grantee that is found to have an unresolved audit finding under an audit conducted under subsection 7b7 may not receive grant funds under a covered grant program in the fiscal year following the fiscal year to which the finding relates4 7d7 ,reimbursement ,if a covered grantee is awarded funds under the covered grant program from which it received a grant award during the #a-;fiscal-year period during which the covered grantee is ineligible for an allocation of grant funds under subsection 7c71 the ,attorney ,general shall-- 7#a7 deposit into the ,general ,fund of the ,treasury an amount that is equal to the amount of the grant funds that were improperly awarded to the covered grantee2 and 7#b7 seek to recoup the costs of the repayment to the ,fund from the covered grantee that was improperly awarded the grant funds4 7e7 ,priority of grant awards ,the ,attorney ,general1 in awarding grants under a covered grant program shall give priority to eligible entities that during the #b-year period preceding the application for a grant have not been found to have an unresolved audit finding4 7f7 ,nonprofit requirements 7#a7 ,prohibition ,a nonprofit organization that holds money in offshore accounts for the purpose of avoiding the tax described in section #eaa7;a7 of the ,internal ,revenue ,code of #aihf1 shall not be eligible to receive1 directly or indirectly1 any funds from a covered grant program4 7#b7 ,disclosure ,each nonprofit organization that is a covered grantee shall disclose in its application for such a grant1 as a condition of receipt of such a grant1 the compensation of its officers1 directors1 and trustees4 ,such disclosure shall include a description of the criteria relied on to determine such compensation4 #bjc4 ,veterans treatment courts ,section #biia of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh 7#db ,u4,s4,c4 #cgig;aa7 is amended-- 7#a7 by redesignating subsection 7i7 as subsection 7j72 and 7#b7 by inserting after subsection 7h7 the following3 7i7 ,assisting veterans 7#a7 ,definitions ,in this subsection3 7,a7 ,peer to peer services or programs ,the term peer to peer services or programs means services or programs that connect qualified veterans with other veterans for the purpose of providing support and mentorship to assist qualified veterans in obtaining treatment1 recovery1 stabilization1 or rehabilitation4 7,b7 ,qualified veteran ,the term qualified veteran means a preliminarily qualified offender who-- 7i7 served on active duty in any branch of the ,armed ,forces1 including the ,national ,guard or ,reserves2 and 7ii7 was discharged or released from such service under conditions other than dishonorable4 7,c7 ,veterans treatment court program ,the term veterans treatment court program means a court program involving collaboration among criminal justice1 veterans1 and mental health and substance abuse agencies that provides qualified veterans with-- 7i7 intensive judicial supervision and case management1 which may include random and frequent drug testing where appropriate2 7ii7 a full continuum of treatment services1 including mental health services1 substance abuse services1 medical services1 and services to address trauma2 7iii7 alternatives to incarceration2 or 7iv7 other appropriate services1 including housing1 transportation1 mentoring1 employment1 job training1 education1 or assistance in applying for and obtaining available benefits4 7#b7 ,veterans assistance program 7,a7 ,in general ,the ,attorney ,general1 in consultation with the ,secretary of ,veterans ,affairs1 may award grants under this subsection to applicants to establish or expand-- 7i7 veterans treatment court programs2 7ii7 peer to peer services or programs for qualified veterans2 7iii7 practices that identify and provide treatment1 rehabilitation1 legal1 transitional1 and other appropriate services to qualified veterans who have been incarcerated2 or 7iv7 training programs to teach criminal justice1 law enforcement1 corrections1 mental health1 and substance abuse personnel how to identify and appropriately respond to incidents involving qualified veterans4 7,b7 ,priority ,in awarding grants under this subsection1 the ,attorney ,general shall give priority to applications that-- 7i7 demonstrate collaboration between and joint investments by criminal justice1 mental health1 substance abuse1 and veterans service agencies2 7ii7 promote effective strategies to identify and reduce the risk of harm to qualified veterans and public safety2 and 7iii7 propose interventions with empirical support to improve outcomes for qualified veterans4 4 #bjd4 ,emergency ,federal law enforcement assistance ,section #fji,y7a7 of the ,justice ,assistance ,act of #aihd 7#db ,u4,s4,c4 #ajeac7;a77 is amended by striking ,september #cj1 #aihd and inserting ,september #cj1 #bjba4 #bje4 ,opioid ,program ,evaluation ,act 7a7 ,short title ,this section may be cited as the ,opioid ,program ,evaluation ,act or the ,,open ,act4 7b7 ,evaluation of performance of ,department of ,justice program 7#a7 ,evaluation of ,justice ,department ,comprehensive ,opioid ,abuse ,grant ,program ,not later than #e years after the date of enactment of this ,act1 the ,attorney ,general shall complete an evaluation of the effectiveness of the ,comprehensive ,opioid ,abuse ,grant ,program under part ,,ll of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh administered by the ,department of ,justice based upon the information reported under paragraph 7#d7 of this subsection4 7#b7 ,interim evaluation ,not later than #c years after the date of enactment of this ,act1 the ,attorney ,general shall complete an interim evaluation assessing the nature and extent of the incidence of opioid abuse and illegal opioid distribution in the ,united ,states4 7#c7 ,metrics and outcomes for evaluation ,not later than #ahj days after the date of enactment of this ,act1 the ,attorney ,general shall identify outcomes that are to be achieved by activities funded by the ,comprehensive ,opioid ,grant ,abuse ,program and the metrics by which the achievement of such outcomes shall be determined4 7#d7 ,metrics data collection ,the ,attorney ,general shall require grantees under the ,comprehensive ,opioid ,abuse ,grant ,program 7and those receiving subawards under section #cjba7;b7 of part ,,ll of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh7 to collect and annually report to the ,department of ,justice data based upon the metrics identified under paragraph 7#c74 7#e7 ,publication of data and findings 7,a7 ,publication of outcomes and metrics ,the ,attorney ,general shall1 not later than #cj days after completion of the requirement under paragraph 7#c71 publish the outcomes and metrics identified under that paragraph4 7,b7 ,publication of evaluation ,in the case of the interim evaluation under paragraph 7#b71 and the final evaluation under paragraph 7#a71 the ,secretary shall arrange for an independent1 external evaluator to1 not later than #ij days after such an evaluation is completed1 publish the results of such evaluation and issue a report on such evaluation to the ,committee on the ,judiciary of the ,house of ,representatives and the ,committee on the ,judiciary of the ,senate4 ,such report shall also be published along with the data used to make such evaluation4 7#f7 ,arrangement with the ,national ,academy of ,sciences ,for purposes of paragraphs 7#a71 7#b71 and 7#c71 the ,attorney ,general shall enter into an arrangement with the ,national ,academy of ,sciences4 7c7 ,evaluation of performance of ,department of ,health and ,human ,services program 7#a7 ,evaluation of ,justice ,department ,comprehensive ,opioid ,abuse ,grant ,program ,not later than #e years after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services shall complete an evaluation of any program administered by the ,secretary that provides grants for the primary purpose of providing assistance in addressing problems pertaining to opioid abuse based upon the information reported under paragraph 7#d7 of this subsection4 7#b7 ,interim evaluation ,not later than #c years after the date of enactment of this ,act1 the ,secretary shall complete an interim evaluation assessing the nature and extent of the incidence of opioid abuse and illegal opioid distribution in the ,united ,states4 7#c7 ,metrics and outcomes for evaluation ,not later than #ahj days after the date of enactment of this ,act1 the ,secretary shall identify outcomes that are to be achieved by activities funded by the programs described in paragraph 7#a7 and the metrics by which the achievement of such outcomes shall be determined4 7#d7 ,metrics data collection ,the ,secretary shall require grantees under the programs described in paragraph 7#a7 to collect and annually report to the ,department of ,health and ,human ,services data based upon the metrics identified under paragraph 7#c74 7#e7 ,publication of data and findings 7,a7 ,publication of outcomes and metrics ,the ,secretary shall1 not later than #cj days after completion of the requirement under paragraph 7#c71 publish the outcomes and metrics identified under that paragraph4 7,b7 ,publication of evaluation ,in the case of the interim evaluation under subparagraph 7,b71 and each final evaluation under paragraph 7#a71 the ,secretary shall arrange for an independent1 external evaluator to1 not later than #ij days after such an evaluation is completed1 publish the results of such evaluation and issue a report on such evaluation to the ,committee on ,energy and ,commerce of the ,house of ,representatives and the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate4 ,such report shall also be published along with the data used to make such evaluation4 7#f7 ,arrangement with an independent1 external evaluator ,for purposes of paragraphs 7#a71 7#b71 7#c71 and 7#e71 the ,secretary shall enter into an arrangement with an independent1 external evaluator4 7d7 ,definition ,in this section1 the term opioid has the meaning given the term opiate in section #ajb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb74 7e7 ,no additional funds authorized ,no additional funds are authorized to be appropriated to carry out this ,act4 #bjf4 ,good ,samaritan ,assessment ,act 7a7 ,,gao ,study on ,good ,samaritan laws pertaining to treatment of opioid overdoses ,the ,comptroller ,general of the ,united ,states shall submit to the ,committee on the ,judiciary of the ,house of ,representatives1 the ,committee on ,oversight and ,government ,reform of the ,house of ,representatives1 the ,committee on the ,judiciary of the ,senate1 and the ,committee on ,homeland ,security and ,governmental ,affairs of the ,senate a report on-- 7#a7 the extent to which the ,director of ,national ,drug ,control ,policy has reviewed ,good ,samaritan laws1 and any findings from such a review1 including findings related to the potential effects of such laws1 if available2 7#b7 efforts by the ,director to encourage the enactment of ,good ,samaritan laws2 and 7#c7 a compilation of ,good ,samaritan laws in effect in the ,states1 the territories1 and the ,district of ,columbia4 7b7 ,definitions ,in this section-- 7#a7 the term ,good ,samaritan law means a law of a ,state or unit of local government that exempts from criminal or civil liability any individual who administers an opioid overdose reversal drug or device1 or who contacts emergency services providers in response to an overdose2 and 7#b7 the term opioid means any drug1 including heroin1 having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having such addiction-forming or addiction-sustaining liability4 ,,iii ,promoting ,responsible ,opioid ,management and ,incorporating ,scientific ,expertise #cja4 ,short title ,this title may be cited as the ,promoting ,responsible ,opioid ,management and ,incorporating ,scientific ,expertise ,act or the ,jason ,simcakoski ,,promise ,act4 ,a ,opioid ,therapy and ,pain ,management #caa4 ,guidelines on management of opioid therapy by ,department of ,veterans ,affairs and ,department of ,defense and implementation of such guidelines by ,department of ,veterans ,affairs 7a7 ,in general ,not later than one year after the date of the enactment of this ,act1 the ,secretary of ,veterans ,affairs and the ,secretary of ,defense shall jointly update the ,,va_/,,dod ,clinical ,practice ,guideline for ,management of ,opioid ,therapy for ,chronic ,pain to include the following3 7#a7 ,in accordance with subsection 7b71 common recommended guidelines for safely prescribing opioids for the treatment of chronic1 non-cancer pain in outpatient settings as compiled by the ,director of the ,centers for ,disease ,control and ,prevention4 7#b7 ,enhanced guidance with respect to-- 7,a7 the administration of two or more drugs that may result in a life-limiting drug-to-drug interaction1 including benzodiazepines2 7,b7 the treatment of patients with current acute psychiatric instability or substance use disorder or patients at risk of suicide2 and 7,c7 the use of opioid therapy to treat mental health disorders other than opioid use disorder4 7#c7 ,enhanced guidance with respect to the treatment of patients with behaviors or comorbidities1 such as post-traumatic stress disorder1 psychiatric disorders1 or a history of substance abuse or addiction1 that requires a consultation or comanagement of opioid therapy with one or more specialists in pain management1 mental health1 or addictions4 7#d7 ,enhanced guidance with respect to the conduct by health care providers of an effective assessment for patients receiving opioid therapy1 including patients on long-term opioid therapy1 to determine-- 7,a7 whether opioid therapy is meeting the expected goals of the patient and health care provider of relieving pain1 improving function1 and providing patient satisfaction2 and 7,b7 whether opioid therapy should be continued4 7#e7 ,guidance that each health care provider of the ,department of ,veterans ,affairs and the ,department of ,defense1 before initiating opioid therapy to treat a patient as part of the comprehensive assessment conducted by the health care provider1 use the ,opioid ,therapy ,risk ,report tool of the ,department of ,veterans ,affairs 7or successor tool71 which shall include the ability to access the most recent patient information from the prescription drug monitoring program of each ,state that has such a program to assess the risk for adverse outcomes of opioid therapy for the patient1 including with respect to the concurrent use of controlled substances1 including benzodiazepines4 7#f7 ,guidelines to govern the methodologies used by health care providers of the ,department of ,veterans ,affairs and the ,department of ,defense to safely titrate and taper opioid therapy when adjusting or discriminating the use of opioid therapy1 including with respect to-- 7,a7 prescription of the lowest effective dose based on patient need2 7,b7 use of opioid only for a limited period of time2 and 7,c7 augmentation of opioid therapy with other pain management therapies and modalities4 7#g7 ,guidelines with respect to appropriate case management for patients receiving opioid therapy who transition between inpatient and outpatient health care settings1 which may include the use of care transition plans4 7#h7 ,guidelines with respect to appropriate transfer of case management responsibility for patients receiving opioid therapy who transition from receiving care furnished by the ,secretary of ,defense to receiving care furnished by other health care providers after the patient has been discharged or separated from the ,armed ,forces4 7#i7 ,enhanced standards with respect to the use of routine and random urine drug tests for all patients before and during opioid therapy to help prevent substance abuse1 dependence1 and diversion1 including-- 7,a7 that such tests occur not less frequently than once each year2 and 7,b7 that health care providers appropriately interpret and respond to the results from such tests to tailor pain therapy1 safeguards1 and risk management strategies to each patient4 7#aj7 ,guidance that health care providers discuss with patients1 before initiating opioid therapy1 options for pain management therapies without the use of opioids and options to augment opioid therapy with other clinical and complementary and integrative health services to minimize opioid dependence4 7b7 ,treatment of certain guidelines developed after deadline ,if the ,director of the ,centers for ,disease ,control and ,prevention issues the guidelines described in paragraph 7#a7 of subsection 7a7 after the date on which the ,secretary of ,veterans ,affairs and the ,secretary of ,defense jointly update the ,,va_/,,dod ,clinical ,practice ,guideline for ,management of ,opioid ,therapy for ,chronic ,pain pursuant to such subsection1 the ,secretaries shall jointly modify the ,,va_/,,dod ,clinical ,practice ,guideline for ,management of ,opioid ,therapy for ,chronic ,pain to incorporate such guidelines of the ,director4 7c7 ,consultation before update ,before updating the guideline under subsection 7a71 the ,secretary of ,veterans ,affairs and the ,secretary of ,defense shall jointly consult with the ,pain ,management ,working ,group of the ,department of ,veterans ,affairs-,department of ,defense ,joint ,executive ,committee established by section #cbj of title #ch1 ,united ,states ,code4 7d7 ,definitions ,in this section3 7#a7 ,the term controlled substance has the meaning given that term in section #ajb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb74 7#b7 ,the term ,state means each of the several ,states1 territories1 and possessions of the ,united ,states1 the ,district of ,columbia1 and the ,commonwealth of ,puerto ,rico4 #cab4 ,improvement of opioid safety measures by ,department of ,veterans ,affairs 7a7 ,expansion of opioid safety initiative ,not later than #ahj days after the date of the enactment of this ,act1 the ,secretary of ,veterans ,affairs shall expand the ,opioid ,safety ,initiative of the ,department of ,veterans ,affairs to include all medical facilities of the ,department4 7b7 ,pain management education and training 7#a7 ,in general ,in carrying out the ,opioid ,safety ,initiative of the ,department1 the ,secretary shall require all employees of the ,department responsible for prescribing opioids to receive education and training described in paragraph 7#b74 7#b7 ,education and training ,education and training described in this paragraph is education and training on pain management and safe opioid prescribing practices for purposes of safely and effectively managing patients with chronic pain1 including education and training on the following3 7,a7 ,the implementation of and full compliance with the ,,va_/,,dod ,clinical ,practice ,guideline for ,management of ,opioid ,therapy for ,chronic ,pain1 including any update to such guideline4 7,b7 ,the use of evidence-based pain management therapies1 including cognitive-behavioral therapy1 non-opioid alternatives1 and non-drug methods and procedures to managing pain and related health conditions including complementary alternative medicines4 7,c7 ,screening and identification of patients with substance use disorder1 including drug-seeking behavior1 before prescribing opioids1 assessment of risk potential for patients developing an addiction1 and referral of patients to appropriate addiction treatment professionals if addiction is identified or strongly suspected4 7,d7 ,communication with patients on the potential harm associated with the use of opioids and other controlled substances1 including the need to safely store and dispose of supplies relating to the use of opioids and other controlled substances4 7,e7 ,such other education and training as the ,secretary considers appropriate to ensure that veterans receive safe and high-quality pain management care from the ,department4 7#c7 ,use of existing program ,in providing education and training described in paragraph 7#b71 the ,secretary shall use the ,interdisciplinary ,chronic ,pain ,management ,training ,team ,program of the ,department 7or success program74 7c7 ,pain management teams 7#a7 ,in general ,in carrying out the ,opioid ,safety ,initiative of the ,department1 the director of each medical facility of the ,department shall identify and designate a pain management team of health care professionals1 which may include board certified pain medicine specialists1 responsible for coordinating and overseeing pain management therapy at such facility for patients experiencing acute and chronic pain that is non-cancer related4 7#b7 ,establishment of protocols 7,a7 ,in general ,in consultation with the ,directors of each ,veterans ,integrated ,service ,network1 the ,secretary shall establish standard protocols for the designation of pain management teams at each medical facility within the ,department4 7,b7 ,consultation on prescription of opioids ,each protocol established under subparagraph 7,a7 shall ensure that any health care provider without expertise in prescribing analgesics or who has not completed the education and training under subsection 7b71 including a mental health care provider1 does not prescribe opioids to a patient unless that health care provider-- 7i7 consults with a health care provider with pain management expertise or who is on the pain management team of the medical facility2 and 7ii7 refers the patient to the pain management team for any subsequent prescriptions and related therapy4 7#c7 ,report 7,a7 ,in general ,not later than one year after the date of enactment of this ,act1 the director of each medical facility of the ,department shall submit to the ,under ,secretary for ,health and the director of the ,veterans ,integrated ,service ,network in which the medical facility is located a report identifying the health care professionals that have been designated as members of the pain management team at the medical facility pursuant to paragraph 7#a74 7,b7 ,elements ,each report submitted under subparagraph 7,a7 with respect to a medical facility of the ,department shall include-- 7i7 a certification as to whether all members of the pain management team at the medical facility have completed the education and training required under subsection 7b72 and 7ii7 a plan for the management and referral of patients to such pain management team if health care providers without expertise in prescribing analgesics prescribe opioid medications to treat acute and chronic pain that is non-cancer related4 7d7 ,tracking and monitoring of opioid use 7#a7 ,prescription drug monitoring programs of states ,in carrying out the ,opioid ,safety ,initiative and the ,opioid ,therapy ,risk ,report tool of the ,department1 the ,secretary shall-- 7,a7 ensure access by health care providers of the ,department to information on controlled substances1 including opioids and benzodiazepines1 prescribed to veterans who receive care outside the ,department through the prescription drug monitoring program of each ,state with such a program1 including by seeking to enter into memoranda of understanding with ,states to allow shared access of such information between ,states and the ,department2 7,b7 include such information in the ,opioid ,therapy ,risk ,report2 and 7,c7 require health care providers of the ,department to submit to the prescription drug monitoring program of each ,state information on prescriptions of controlled substances received by veterans in that ,state under the laws administered by the ,secretary4 7#b7 ,report on tracking of data on opioid use ,not later than #ah months after the date of the enactment of this ,act1 the ,secretary shall submit to the ,committee on ,veterans' ,affairs of the ,senate and the ,committee on ,veterans' ,affairs of the ,house of ,representatives a report on the feasibility and advisability of improving the ,opioid ,therapy ,risk ,report tool of the ,department to allow for more advanced real-time tracking of and access to data on-- 7,a7 the key clinical indicators with respect to the totality of opioid use by veterans2 7,b7 concurrent prescribing by health care providers of the ,department of opioids in different health care settings1 including data on concurrent prescribing of opioids to treat mental health disorders other than opioid use disorder2 and 7,c7 mail-order prescriptions of opioid prescribed to veterans under the laws administered by the ,secretary4 7e7 ,availability of opioid receptor antagonists 7#a7 ,increased availability and use 7,a7 ,in general ,the ,secretary shall maximize the availability of opioid receptor antagonists approved by the ,food and ,drug ,administration1 including naloxone1 to veterans4 7,b7 ,availability1 training1 and distributing ,in carrying out subparagraph 7,a71 not later than #ij days after the date of the enactment of this ,act1 the ,secretary shall-- 7i7 equip each pharmacy of the ,department with opioid receptor antagonists approved by the ,food and ,drug ,administration to be dispensed to outpatients as needed2 and 7ii7 expand the ,overdose ,education and ,naloxone ,distribution program of the ,department to ensure that all veterans in receipt of health care under laws administered by the ,secretary who are at risk of opioid overdose may access such opioid receptor antagonists and training on the proper administration of such opioid receptor antagonists4 7,c7 ,veterans who are at risk ,for purposes of subparagraph 7,b71 veterans who are at risk of opioid overdose include-- 7i7 veterans receiving long-term opioid therapy2 7ii7 veterans receiving opioid therapy who have a history of substance use disorder or prior instances of overdose2 and 7iii7 veterans who are at risk as determined by a health care provider who is treating the veteran4 7#b7 ,report ,not later than #abj days after the date of the enactment of this ,act1 the ,secretary shall submit to the ,committee on ,veterans' ,affairs of the ,senate and the ,committee on ,veterans' ,affairs of the ,house of ,representatives a report on carrying out paragraph 7#a71 including an assessment of any remaining steps to be carried out by the ,secretary to carry out such paragraph4 7f7 ,inclusion of certain information and capabilities in opioid therapy risk report tool of the ,department 7#a7 ,information ,the ,secretary shall include in the ,opioid ,therapy ,risk ,report tool of the ,department-- 7,a7 information on the most recent time the tool was accessed by a health care provider of the ,department with respect to each veteran2 and 7,b7 information on the results of the most recent urine drug test for each veteran4 7#b7 ,capabilities ,the ,secretary shall include in the ,opioid ,therapy ,risk ,report tool the ability of the health care providers of the ,department to determine whether a health care provider of the ,department prescribed opioids to a veteran without checking the information in the tool with respect to the veteran4 7g7 ,notifications of risk in computerized health record ,the ,secretary shall modify the computerized patient record system of the ,department to ensure that any health care provider that accesses the record of a veteran1 regardless of the reason the veteran seeks care from the health care provider1 will be immediately notified whether the veteran-- 7#a7 is receiving opioid therapy and has a history of substance use disorder or prior instances of overdose2 7#b7 has a history of opioid abuse2 or 7#c7 is at risk of becoming an opioid abuser as determined by a health care provider who is treating the veteran4 7h7 ,definitions ,in this section3 7#a7 ,the term controlled substance has the meaning given that term in section #ajb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb74 7#b7 ,the term ,state means each of the several ,states1 territories1 and possessions of the ,united ,states1 the ,district of ,columbia1 and the ,commonwealth of ,puerto ,rico4 #cac4 ,strengthening of joint working group on pain management of the ,department of ,veterans ,affairs and the ,department of ,defense 7a7 ,in general ,not later than #ij days after the date of enactment of this ,act1 the ,secretary of ,veterans ,affairs and the ,secretary of ,defense shall ensure that the ,pain ,management ,working ,group of the ,health ,executive ,committee of the ,department of ,veterans ,affairs-,department of ,defense ,joint ,executive ,committee established under section #cbj of title #ch1 ,united ,states ,code1 includes a focus on the following3 7#a7 ,the opioid prescribing practices of health care providers of each ,department4 7#b7 ,the ability of each ,department to manage acute and chronic pain among individuals receiving health care from the ,department1 including training health care providers with respect to pain management4 7#c7 ,the use by each ,department of complementary and integrative health and complementary alternative medicines in treating such individuals4 7#d7 ,the concurrent use by health care providers of each ,department of opioids and prescription drugs to treat mental health disorders1 including benzodiazepines4 7#e7 ,the practice by health care providers of each ,department of prescribing opioids to treat mental health disorders4 7#f7 ,the coordination in coverage of and consistent access to medications prescribed for patients transitioning from receiving health care from the ,department of ,defense to receiving health care from the ,department of ,veterans ,affairs4 7#g7 ,the ability of each ,department to identify and treat substance use disorders among individuals receiving health care from that ,department4 7b7 ,coordination and consultation ,the ,secretary of ,veterans ,affairs and the ,secretary of ,defense shall ensure that the working group described in subsection 7a7-- 7#a7 coordinates the activities of the working group with other relevant working groups established under section #cbj of title #ch1 ,united ,states ,code1 including the working groups on evidence-based practice1 patient safety1 pharmacy1 psychological health1 and psychological health2 7#b7 consults with other relevant ,federal agencies1 including the ,centers for ,disease ,control and ,prevention1 with respect to the activities of the working group2 and 7#c7 consults with the ,department of ,veterans ,affairs and the ,department of ,defense with respect to1 reviews1 and comments on the ,,va_/,,dod ,clinical ,practice ,guideline for ,management of ,opioid ,therapy for ,chronic ,pain1 or any successor guideline1 before any update to the guideline is released4 7c7 ,consultations ,the ,secretary of ,veterans ,affairs and the ,secretary of ,defense shall ensure that the working group described in subsection 7a7 is able to meaningfully consult with respect to the updated guideline required under subsection 7a7 of section #caa1 as required by subsection 7b7 of such section1 not later than #a year after the date of enactment of this ,act4 #cad4 ,review1 investigation1 and report on use of opioids in treatment by ,department of ,veterans ,affairs 7a7 ,comptroller general report 7#a7 ,in general ,not later than two years after the date of the enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall submit to the ,committee on ,veterans' ,affairs of the ,senate and the ,committee on ,veterans' ,affairs of the ,house of ,representatives a report on the ,opioid ,safety ,initiative of the ,department of ,veterans ,affairs and the opioid prescribing practices of health care providers of the ,department4 7#b7 ,elements ,the report submitted under paragraph 7#a7 shall include the following3 7,a7 ,recommendations on such improvements to the ,opioid ,safety ,initiative of the ,department as the ,comptroller ,general considers appropriate4 7,b7 ,information with respect to-- 7i7 deaths resulting from sentinel events involving veterans prescribed opioids by a health care provider of the ,department2 7ii7 overall prescription rates and prescriptions indications of opioids to treat non-cancer1 non-palliative1 and non-hospice care patients2 7iii7 the prescription rates and prescriptions indications of benzodiazepines and opioids concomitantly by health care providers of the ,department2 7iv7 the practice by health care providers of the ,department of prescribing opioids to treat patients without any pain1 including to treat patients with mental health disorders other than opioid use disorder2 and 7v7 the effectiveness of opioid therapy for patients receiving such therapy1 including the effectiveness of long-term opioid therapy4 7,c7 ,an evaluation of processes of the ,department in place to oversee opioid use among veterans1 including procedures to identify and remedy potential over-prescribing of opioids by health care providers of the ,department4 7,d7 ,an assessment of the implementation by the ,secretary of the ,,va_/,,dod ,clinical ,practice ,guideline for ,management of ,opioid ,therapy for ,chronic ,pain4 7b7 ,quarterly progress report on implementation of comptroller general recommendations ,not later than two years after the date of the enactment of this ,act1 and not later than #cj days after the end of each quarter thereafter1 the ,secretary of ,veterans ,affairs shall submit to the ,committee on ,veterans' ,affairs of the ,senate and the ,committee on ,veterans' ,affairs of the ,house of ,representatives a progress report detailing the actions by the ,secretary during the period covered by the report to address any outstanding findings and recommendations by the ,comptroller ,general of the ,united ,states under subsection 7a7 with respect to the ,veterans ,health ,administration4 7c7 ,annual review of prescription rates ,not later than one year after the date of the enactment of this ,act1 and not less frequently than annually for the following five years1 the ,secretary shall submit to the ,committee on ,veterans' ,affairs of the ,senate and the ,committee on ,veterans' ,affairs of the ,house of ,representatives a report1 with respect to each medical facility of the ,department of ,veterans ,affairs1 to collect and review information on opioids prescribed by health care providers at the facility to treat non-cancer1 non-palliative1 and non-hospice care patients that contains1 for the one-year period preceding the submission of the report1 the following3 7#a7 ,the number of patients and the percentage of the patient population of the ,department who were prescribed benzodiazepines and opioids concurrently by a health care provider of the ,department4 7#b7 ,the number of patients and the percentage of the patient population of the ,department without any pain who were prescribed opioids by a health care provider of the ,department1 including those who were prescribed benzodiazepines and opioids concurrently4 7#c7 ,the number of non-cancer1 non-palliative1 and non-hospice care patients and the percentage of such patients who were treated with opioids by a health care provider of the ,department on an inpatient-basis and who also received prescription opioids by mail from the ,department while being treated on an inpatient-basis4 7#d7 ,the number of non-cancer1 non-palliative1 and non-hospice care patients and the percentage of such patients who were prescribed opioids concurrently by a health care provider of the ,department and a health care provider that is not health care provider of the ,department4 7#e7 ,with respect to each medical facility of the ,department1 information on opioids prescribed by health care providers at the facility to treat non-cancer1 non-palliative1 and non-hospice care patients1 including information on-- 7,a7 the prescription rate at which each health care provider at the facility prescribed benzodiazepines and opioids concurrently to such patients and the aggregate such prescription rate for all health care providers at the facility2 7,b7 the prescription rate at which each health care provider at the facility prescribed benzodiazepines or opioids to such patients to treat conditions for which benzodiazepines or opioids are not approved treatment and the aggregate such prescription rate for all health care providers at the facility2 7,c7 the prescription rate at which each health care provider at the facility prescribed or dispensed mail-order prescriptions of opioids to such patients while such patients were being treated with opioids on an inpatient-basis and the aggregate of such prescription rate for all health care providers at the facility2 and 7,d7 the prescription rate at which each health care provider at the facility prescribed opioids to such patients who were also concurrently prescribed opioids by a health care provider that is not a health care provider of the ,department and the aggregate of such prescription rates for all health care providers at the facility4 7#f7 ,with respect to each medical facility of the ,department1 the number of times a pharmacist at the facility overrode a critical drug interaction warning with respect to an interaction between opioids and another medication before dispensing such medication to a veteran4 7d7 ,investigation of prescription rates ,if the ,secretary determines that a prescription rate with respect to a health care provider or medical facility of the ,department conflicts with or is otherwise inconsistent with the standards of appropriate and safe care1 the ,secretary shall-- 7#a7 immediately notify the ,committee on ,veterans' ,affairs of the ,senate and the ,committee on ,veterans' ,affairs of the ,house of ,representatives of such determination1 including information relating to such determination1 prescription rate1 and health care provider or medical facility1 as the case may be2 and 7#b7 through the ,office of the ,medical ,inspector of the ,veterans ,health ,administration1 conduct a full investigation of the health care provider or medical facility1 as the case may be4 7e7 ,prescription rate defined ,in this section1 the term prescription rate means1 with respect to a health care provider or medical facility of the ,department1 each of the following3 7#a7 ,the number of patients treated with opioids by the health care provider or at the medical facility1 as the case may be1 divided by the total number of pharmacy users of that health care provider or medical facility4 7#b7 ,the average number of morphine equivalents per day prescribed by the health care provider or at the medical facility1 as the case may be1 to patients being treated with opioids4 7#c7 ,of the patients being treated with opioids by the health care provider or at the medical facility1 as the case may be1 the average number of prescriptions of opioids per patient4 ,b ,patient ,advocacy #cba4 ,community meetings on improving care furnished by ,department of ,veterans ,affairs 7a7 ,community meetings 7#a7 ,medical centers ,not later than #ij days after the date of the enactment of this ,act1 and not less frequently than once every #ij days thereafter1 the ,secretary shall ensure that each medical facility of the ,department of ,veterans ,affairs hosts a community meeting open to the public on improving health care furnished by the ,secretary4 7#b7 ,community based outpatient clinics ,not later than one year after the date of the enactment of this ,act1 and not less frequently than annually thereafter1 the ,secretary shall ensure that each community based outpatient clinic of the ,department hosts a community meeting open to the public on improving health care furnished by the ,secretary4 7b7 ,attendance by ,director of veterans integrated service network or designee 7#a7 ,in general ,each community meeting hosted by a medical facility or community based outpatient clinic under subsection 7a7 shall be attended by the ,director of the ,veterans ,integrated ,service ,network in which the medical facility or community based outpatient clinic1 as the case may be1 is located4 ,subject to paragraph 7#b71 the ,director may delegate such attendance only to an employee who works in the ,office of the ,director4 7#b7 ,attendance by director ,each ,director of a ,veterans ,integrated ,service ,network shall personally attend not less than one community meeting under subsection 7a7 hosted by each medical facility located in the ,veterans ,integrated ,service ,network each year4 7c7 ,notice ,the ,secretary shall notify the ,committee on ,veterans' ,affairs of the ,senate1 the ,committee on ,veterans' ,affairs of the ,house of ,representatives1 and each ,member of ,congress 7as defined in section #cad7 who represents the area in which the medical facility is located of a community meeting under subsection 7a7 by not later than #aj days before such community meeting occurs4 #cbb4 ,improvement of awareness of patient advocacy program and patient bill of rights of ,department of ,veterans ,affairs ,not later than #ij days after the date of the enactment of this ,act1 the ,secretary of ,veterans ,affairs shall1 in as many prominent locations as the ,secretary determines appropriate to be seen by the largest percentage of patients and family members of patients at each medical facility of the ,department of ,veterans ,affairs-- 7#a7 display the purposes of the ,patient ,advocacy ,program of the ,department and the contact information for the patient advocate at such medical facility2 and 7#b7 display the rights and responsibilities of-- 7,a7 patients and family members and patients at such medical facility2 and 7,b7 with respect to community living centers and other residential facilities of the ,department1 residents and family members of residents at such medical facility4 #cbc4 ,comptroller general report on patient advocacy program of ,department of ,veterans ,affairs 7a7 ,in general ,not later than two years after the date of the enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall submit to the ,committee on ,veterans' ,affairs of the ,senate and the ,committee on ,veterans' ,affairs of the ,house of ,representatives a report on the ,patient ,advocacy ,program of the ,department of ,veterans ,affairs 7in this section referred to as the ,program74 7b7 ,elements ,the report required by subsection 7a7 shall include the following3 7#a7 ,a description of the ,program1 including-- 7,a7 the purpose of the ,program2 7,b7 the activities carried out under the ,program2 and 7,c7 the sufficiency of the ,program in achieving the purpose of the ,program4 7#b7 ,an assessment of the sufficiency of staffing of employees of the ,department responsible for carrying out the ,program4 7#c7 ,an assessment of the sufficiency of the training of such employees4 7#d7 ,an assessment of-- 7,a7 the awareness of the ,program among veterans and family members of veterans2 and 7,b7 the use of the ,program by veterans and family members of veterans4 7#e7 ,such recommendations and proposals for improving or modifying the ,program as the ,comptroller ,general considers appropriate4 7#f7 ,such other information with respect to the ,program as the ,comptroller ,general considers appropriate4 ,c ,complementary and ,integrative ,health #cca4 ,expansion of research and education on and delivery of complementary and integrative health to veterans 7a7 ,establishment ,there is established a commission to be known as the ,creating ,options for ,veterans' ,expedited ,recovery or the ,,cover ,commission 7in this ,act referred to as the ,commission74 ,the ,commission shall examine the evidence-based therapy treatment model used by the ,secretary of ,veterans ,affairs for treating mental health conditions of veterans and the potential benefits of incorporating complementary alternative treatments available in non-,department facilities 7as defined in section #agja of title #ch1 ,united ,states ,code74 7b7 ,duties ,the ,commission shall perform the following duties3 7#a7 ,examine the efficacy of the evidence-based therapy model used by the ,secretary for treating mental health illnesses of veterans and identify areas to improve wellness-based outcomes4 7#b7 ,conduct a patient-centered survey within each of the ,veterans ,integrated ,service ,networks to examine-- 7,a7 the experience of veterans with the ,department of ,veterans ,affairs when seeking medical assistance for mental health issues through the health care system of the ,department2 7,b7 the experience of veterans with non-,department facilities and health professionals for treating mental health issues2 7,c7 the preference of veterans regarding available treatment for mental health issues and which methods the veterans believe to be most effective2 7,d7 the experience1 if any1 of veterans with respect to the complementary alternative treatment therapies described in paragraph 7#c72 7,e7 the prevalence of prescribing prescription medication among veterans seeking treatment through the health care system of the ,department as remedies for addressing mental health issues2 and 7,f7 the outreach efforts of the ,secretary regarding the availability of benefits and treatments for veterans for addressing mental health issues1 including by identifying ways to reduce barriers to gaps in such benefits and treatments4 7#c7 ,examine available research on complementary alternative treatment therapies for mental health issues and identify what benefits could be made with the inclusion of such treatments for veterans1 including with respect to-- 7,a7 music therapy2 7,b7 equine therapy2 7,c7 training and caring for service dogs2 7,d7 yoga therapy2 7,e7 acupuncture therapy2 7,f7 meditation therapy2 7,g7 outdoor sports therapy2 7,h7 hyperbaric oxygen therapy2 7,i7 accelerated resolution therapy2 7,j7 art therapy2 7,k7 magnetic resonance therapy2 and 7,l7 other therapies the ,commission determines appropriate4 7#d7 ,study the sufficiency of the resources of the ,department to ensure the delivery of quality health care for mental health issues among veterans seeking treatment within the ,department4 7#e7 ,study the current treatments and resources available within the ,department and assess-- 7,a7 the effectiveness of such treatments and resources in decreasing the number of suicides per day by veterans2 7,b7 the number of veterans who have been diagnosed with mental health issues2 7,c7 the percentage of veterans using the resources of the ,department who have been diagnosed with mental health issues2 7,d7 the percentage of veterans who have completed counseling sessions offered by the ,department2 and 7,e7 the efforts of the ,department to expand complementary alternative treatments viable to the recovery of veterans with mental health issues as determined by the ,secretary to improve the effectiveness of treatments offered with the ,department4 7c7 ,membership 7#a7 ,in general ,the ,commission shall be composed of #aj members1 appointed as follows3 7,a7 ,two members appointed by the ,speaker of the ,house of ,representatives1 at least one of whom shall be a veteran4 7,b7 ,two members appointed by the ,minority ,leader of the ,house of ,representatives1 at least one of whom shall be a veteran4 7,c7 ,two members appointed by the ,majority ,leader of the ,senate1 at least one of whom shall be a veteran4 7,d7 ,two members appointed by the ,minority ,leader of the ,senate1 at least one of whom shall be a veteran4 7,e7 ,two members appointed by the ,president1 at least one of whom shall be a veteran4 7#b7 ,qualifications ,members of the ,commission shall be-- 7,a7 individuals who are of recognized standing and distinction within the medical community with a background in treating mental health2 7,b7 individuals with experience working with the military and veteran population2 and 7,c7 individuals who do not have a financial interest in any of the complementary alternative treatments reviewed by the ,commission4 7#c7 ,chairman ,the ,president shall designate a member of the ,commission to be the ,chairman4 7#d7 ,period of appointment ,members of the ,commission shall be appointed for the life of the ,commission4 7#e7 ,vacancy ,a vacancy in the ,commission shall be filled in the manner in which the original appointment was made4 7#f7 ,appointment deadline ,the appointment of members of the ,commission in this section shall be made not later than #ij days after the date of the enactment of this ,act4 7d7 ,powers of commission 7#a7 ,meetings 7,a7 ,initial meeting ,the ,commission shall hold its first meeting not later than #cj days after a majority of members are appointed to the ,commission4 7,b7 ,meeting ,the ,commission shall regularly meet at the call of the ,chairman4 ,such meetings may be carried out through the use of telephonic or other appropriate telecommunication technology if the ,commission determines that such technology will allow the members to communicate simultaneously4 7#b7 ,hearings ,the ,commission may hold such hearings1 sit and act at such times and places1 take such testimony1 and receive evidence as the ,commission considers advisable to carry out the responsibilities of the ,commission4 7#c7 ,information from federal agencies ,the ,commission may secure directly from any department or agency of the ,federal ,government such information as the ,commission considers necessary to carry out the duties of the ,commission4 7#d7 ,information from nongovernmental organizations ,in carrying out its duties1 the ,commission may seek guidance through consultation with foundations1 veteran service organizations1 nonprofit groups1 faith-based organizations1 private and public institutions of higher education1 and other organizations as the ,commission determines appropriate4 7#e7 ,commission records ,the ,commission shall keep an accurate and complete record of the actions and meeting of the ,commission4 ,such record shall be made available for public inspection and the ,comptroller ,general of the ,united ,states may audit and examine such record4 7#f7 ,personnel records ,the ,commission shall keep an accurate and complete record of the actions and meetings of the ,commission4 ,such record shall be made available for public inspection and the ,comptroller ,general of the ,united ,states may audit and examine such records4 7#g7 ,compensation of members2 travel expenses ,each member shall serve without pay but shall receive travel expenses to perform the duties of the ,commission1 including per diem in lieu of substances1 at rates authorized under subchapter ,i of chapter #eg of title #e1 ,united ,states ,code4 7#h7 ,staff ,the ,chairman1 in accordance with rules agreed upon the ,commission1 may appoint fix the compensation of a staff director and such other personnel as may be necessary to enable the ,commission to carry out its functions1 without regard to the provisions of title #e1 ,united ,states ,code1 governing appointments in the competitive service1 without regard to the provision of chapter #ea and subchapter ,,iii of chapter #ec of such title relating to classification and ,general ,schedule pay rates1 except that no rate of pay fixed under this paragraph may exceed the equivalent of that payable for a position at a level ,,iv of the ,executive ,schedule under section #ecaf of title #e1 ,united ,states ,code4 7#i7 ,personnel as federal employees 7,a7 ,in general ,the executive director and any personnel of the ,commission are employees under section #baje of title #e1 ,united ,states ,code1 for purpose of chapters #fc1 #ha1 #hc1 #hd1 #he1 #hg1 #hi1 and #ij of such title4 7,b7 ,members of the commission ,subparagraph 7,a7 shall not be construed to apply to members of the ,commission4 7#aj7 ,contracting ,the ,commission may1 to such extent and in such amounts as are provided in appropriations ,acts1 enter into contracts to enable the ,commission to discharge the duties of the ,commission under this ,act4 7#aa7 ,expert and consultant service ,the ,commission may procure the services of experts and consultants in accordance with section #caji or title #e1 ,united ,states ,code1 at rates not to exceed the daily rate paid to a person occupying a position at level ,,iv of the ,executive ,schedule under section #caji of title #e1 ,united ,states ,code4 7#ab7 ,postal service ,the ,commission may use the ,united ,states mails in the same manner and under the same conditions as departments and agencies of the ,united ,states4 7#ac7 ,physical facilities and equipment ,upon the request of the ,commission1 the ,administrator of ,general ,services shall provide to the ,commission1 on a reimbursable basis1 the administrative support services necessary for the ,commission to carry out its responsibilities under this ,act4 ,these administrative services may include human resource management1 budget1 leasing accounting1 and payroll services4 7e7 ,report 7#a7 ,interim reports 7,a7 ,in general ,not later than #fj days after the date on which the ,commission first meets1 and each #cj-;day period thereafter ending on the date on which the ,commission submits the final report under paragraph 7#b71 the ,commission shall submit to the ,committees on ,veterans' ,affairs of the ,house of ,representatives and the ,senate and the ,president a report detailing the level of cooperation the ,secretary of ,veterans ,affairs 7and the heads of other departments or agencies of the ,federal ,government7 has provided to the ,commission4 7,b7 ,other reports ,in carrying out its duties1 at times that the ,commission determines appropriate1 the ,commission shall submit to the ,committee on ,veterans' ,affairs of the ,house of ,representatives and the ,senate and any other appropriate entities an interim report with respect to the findings identified by the ,commission4 7#b7 ,final report ,not later than #ah months after the first meeting of the ,commission1 the ,commission shall submit to the ,committee on ,veterans' ,affairs of the ,house of ,representatives and the ,senate1 the ,president1 and the ,secretary of ,veterans ,affairs a final report on the findings of the ,commission4 ,such report shall include the following3 7,a7 ,recommendations to implement in a feasible1 timely1 and cost efficient manner the solutions and remedies identified within the findings of the ,commission pursuant to subsection 7b74 7,b7 ,an analysis of the evidence-based therapy model used by the ,secretary of ,veterans ,affairs for treating veterans with mental health care issues1 and an examination of the prevalence and efficacy of prescription drugs as a means for treatment4 7,c7 ,the findings of the patient-centered survey conducted within each of the ,veterans ,integrated ,service ,networks pursuant to subsection 7b77#b74 7,d7 ,an examination of complementary alternative treatments described in subsection 7b77#c7 and the potential benefits of incorporating such treatments in the therapy models used by the ,secretary for treating veterans with mental health issues4 7#c7 ,plan ,not later than #ij days after the date on which the ,commission submits the final report under paragraph 7#b71 the ,secretary of ,veterans ,affairs shall submit to the ,committee on ,veterans' ,affairs of the ,house of ,representatives and the ,senate a report on the following3 7,a7 ,an action plan for implementing the recommendations established by the ,commission on such solutions and remedies for improving wellness-based outcomes for veterans with mental health care issues4 7,b7 ,a feasible timeframe on when the complementary alternative treatments described in subsection 7b77#c7 can be implemented ,department-wide4 7,c7 ,with respect to each recommendation established by the ,commission1 including any complementary alternative treatment1 that the ,secretary determines is not appropriate or feasible to implement1 a justification for such determination and an alternative solution to improve the efficacy of the therapy models used by the ,secretary for treating veterans with mental health issues4 7f7 ,termination of commission ,the ,commission shall terminate #cj days after the ,commission submits the final report under subsection 7e77#b74 #ccb4 ,pilot program on integration of complementary alternative medicines and related issues for veterans and family members of veterans 7a7 ,pilot program 7#a7 ,in general ,not later than #ahj days after the date on which the ,secretary of ,veterans ,affairs receives the final report under section #cca7;e71 the ,secretary shall commence a pilot program to assess the feasibility and advisability of using wellness-based programs 7as defined by the ,secretary7 to complement the provision of pain management and related health care services1 including mental health care services1 to veterans4 7#b7 ,matters addressed ,in carrying out the pilot program1 the ,secretary shall assess the following3 7,a7 ,means of improving coordination between ,federal1 ,state1 local1 and community providers of health care in the provision of pain management and related health care services to veterans4 7,b7 ,means of enhancing outreach1 and coordination of outreach1 by and among providers of health care referred to in subparagraph 7,a7 on the pain management and related health care services available to veterans4 7,c7 ,means of using wellness-based programs of providers of health care referred to in subparagraph 7,a7 as complements to the provision by the ,department of pain management and related health care services to veterans4 7,d7 ,whether wellness-based programs described in subparagraph 7,c7-- 7i7 are effective in enhancing the quality of life and well-being of veterans2 7ii7 are effective in increasing the adherence of veterans to the primary pain management and related health care services provided such veterans by the ,department2 7iii7 have an effect on the sense of well-being of veterans who receive primary pain management and related health care services from the ,department2 and 7iv7 are effective in encouraging veterans receiving health care from the ,department to adopt a more healthy lifestyle4 7b7 ,duration ,the ,secretary shall carry out the pilot program under subsection 7a77#a7 for a period of three years4 7c7 ,locations 7#a7 ,facilities ,the ,secretary shall carry out the pilot program under subsection 7a77#a7 at facilities of the ,department providing pain management and related health care services1 including mental health care services1 to veterans4 ,in selecting such facilities to carry out the pilot program1 the ,secretary shall select not fewer than #ae medical centers of the ,department1 of which not fewer than two shall be polytrauma rehabilitation centers of the ,department4 7#b7 ,medical centers with prescription rates of opioids that conflict with care standards ,in selecting the medical centers under paragraph 7#a71 the ,secretary shall give priority to medical centers of the ,department at which there is a prescription rate of opioids that conflicts with or is otherwise inconsistent with the standards of appropriate and safe care4 7d7 ,provision of services ,under the pilot program under subsection 7a77#a71 the ,secretary shall provide covered services to covered veterans by integrating complementary and alternative medicines and integrative health services with other services provided by the ,department at the medical centers selected under subsection 7c74 7e7 ,covered veterans ,for purposes of the pilot program under subsection 7a77#a71 a covered veteran is any veteran who-- 7#a7 has a mental health condition diagnosed by a clinician of the ,department2 7#b7 experiences chronic pain2 7#c7 has a chronic condition being treated by a clinician of the ,department2 or 7#d7 is not described in paragraph 7#a71 7#b71 or 7#c7 and requests to participate in the pilot program or is referred by a clinician of the ,department who is treating the veteran4 7f7 ,covered services 7#a7 ,in general ,for purposes of the pilot program1 covered services are services consisting of complementary and integrative health services as selected by the ,secretary4 7#b7 ,administration of services ,covered services shall be administered under the pilot program as follows3 7,a7 ,covered services shall be administered by professionals or other instructors with appropriate training and expertise in complementary and integrative health services who are employees of the ,department or with whom the ,department enters into an agreement to provide such services4 7,b7 ,covered services shall be included as part of the ,patient ,aligned ,care ,teams initiative of the ,office of ,patient ,care ,services1 ,primary ,care ,program ,office1 in coordination with the ,office of ,patient ,centered ,care and ,cultural ,transformation4 7,c7 ,covered services shall be made available to-- 7i7 covered veterans who have received conventional treatments from the ,department for the conditions for which the covered veteran seeks complementary and integrative health services under the pilot program2 and 7ii7 covered veterans who have not received conventional treatments from the ,department for such conditions4 7g7 ,reports 7#a7 ,in general ,not later than #cj months after the date on which the ,secretary commences the pilot program under subsection 7a77#a71 the ,secretary shall submit to the ,committee on ,veterans' ,affairs of the ,senate and the ,committee on ,veterans' ,affairs of the ,house of ,representatives a report on the pilot program4 7#b7 ,elements ,the report under paragraph 7#a7 shall include the following3 7,a7 ,the findings and conclusions of the ,secretary with respect to the pilot program under subsection 7a77#a71 including with respect to-- 7i7 the use and efficacy of the complementary and integrative health services established under the pilot program2 7ii7 the outreach conducted by the ,secretary to inform veterans and community organizations about the pilot program2 and 7iii7 an assessment of the benefit of the pilot program to covered veterans in mental health diagnoses1 pain management1 and treatment of chronic illness4 7,b7 ,identification of any unresolved barriers that impede the ability of the ,secretary to incorporate complementary and integrative health services with other health care services provided by the ,department4 7,c7 ,such recommendations for the continuation or expansion of the pilot program as the ,secretary considers appropriate4 7h7 ,complementary and integrative health defined ,in this section1 the term complementary and integrative health shall have the meaning given that term by the ,national ,institutes of ,health4 ,d ,fitness of ,health ,care ,providers #cda4 ,additional requirements for hiring of health care providers by ,department of ,veterans ,affairs ,as part of the hiring process for each health care provider considered for a position at the ,department of ,veterans ,affairs after the date of the enactment of the ,act1 the ,secretary of ,veterans ,affairs shall require from the medical board of each ,state in which the health care provider has a medical license-- 7#a7 information on any violation of the requirements of the medical license of the health care provider during the #bj-year period preceding the consideration of the health care provider by the ,department2 and 7#b7 information on whether the health care provider has entered into any settlement agreement for the disciplinary charge relating to the practice of medicine by the health care provider4 #cdb4 ,provision of information on health care providers of ,department of ,veterans ,affairs to ,state ,medical ,boards ,notwithstanding section #eeb;a of title #e1 ,united ,states ,code1 with respect to each health care provider of the ,department of ,veterans ,affairs who has violated a requirement of the medical license of the health care provider1 the ,secretary of ,veterans ,affairs shall provide to the medical board of each ,state in which the health care provider is licensed detailed information with respect to such violation1 regardless of whether such board has formally requested such information4 #cdc4 ,report on compliance by ,department of ,veterans ,affairs with reviews of health care providers leaving the ,department or transferring to other facilities ,not later than two years after the date of the enactment of this ,act1 the ,secretary of ,veterans ,affairs shall submit to the ,committee on ,veterans' ,affairs of the ,senate and the ,committee on ,veterans' ,affairs of the ,house of ,representatives a report on the compliance by the ,department of ,veterans ,affairs with the policy of the ,department-- 7#a7 to conduct a review of each health care provider of the ,department who transfers to another medical facility of the ,department1 retires1 or is terminated to determine whether there are any concerns1 complaints1 or allegations of violations relating to the medical practice of the health care provider2 and 7#b7 to take appropriate action with respect to any such concern1 complaint1 or allegation4 ,e ,other ,veterans ,matters #cea4 ,audit of ,veterans ,health ,administration programs of ,department of ,veterans ,affairs 7a7 ,audit ,the ,secretary of ,veterans ,affairs shall seek to enter into a contract with a nongovernmental entity under which the entity shall conduct a audits of the programs of the ,veterans ,health ,administration of the ,department of ,veterans ,affairs to identify ways to improve the furnishing of benefits and health care administered by the ,veterans ,health ,administration to veterans and families of veterans4 7b7 ,audit requirements ,in carrying out each audit under subsection 7a71 the entity shall perform the following3 7#a7 ,five-year risk assessments to identify the functions1 staff organizations1 and staff offices of the ,veterans ,health ,administration that would lead towards the greatest improvement in furnishing of benefits and health care to veterans and families of veterans4 7#b7 ,development of plans that are informed by the risk assessment under paragraph 7#a7 to conduct audits of the functions1 staff organizations1 and staff offices identified under paragraph 7#a74 7#c7 ,conduct audits in accordance with the plans developed pursuant to paragraph 7#b74 7c7 ,reports ,not later than #ij days after the date on which each audit is completed under subsection 7a71 the ,secretary shall submit to the ,committees on ,veterans' ,affairs of the ,house of ,representatives and the ,senate a report that includes-- 7#a7 a summary of the audit2 7#b7 the findings of the entity that conducted the audit with respect to the audit2 and 7#c7 such recommendations as the ,secretary determines appropriate for legislative or administrative action to improve the furnishing of benefits and health care to veterans and families of veterans4 ,,iv ,improving ,safe ,care for ,preventing ,infant ,abuse and ,neglect #dja4 ,short title ,this title may be cited as the ,improving ,safe ,care for the ,prevention of ,infant ,abuse and ,neglect ,act4 #djb4 ,best practices for development of plans of safe care ,section #ajc7;b7 of the ,child ,abuse ,prevention and ,treatment ,act 7#db ,u4,s4,c4 #eajd7;b77 is amended-- 7#a7 by redesignating paragraphs 7#e7 through 7#h7 as paragraphs 7#f7 through 7#i71 respectively2 and 7#b7 by inserting after paragraph 7#d71 the following3 7#e7 maintain and disseminate information about the best practices relating to the development of plans of safe care as described in section #ajf7;b77#b77;,b77iii7 for infants born and identified as being affected by illegal substance abuse or withdrawal symptoms1 or a ,fetal ,alcohol ,spectrum ,disorder2 4 #djc4 ,state plans ,section #ajf7;b77#b77;,b77iii7 of the ,child ,abuse ,prevention and ,treatment ,act 7#db ,u4,s4,c4 #eajf;a7b77#b77;,b77iii77 is amended by inserting before the period at the end the following3 to ensure the safety and well-being of such infant following release from the care of healthcare providers1 including through addressing the health of the affected family or caregiver4 #djd4 ,data reports 7a7 ,in general ,section #ajf7;d7 of the ,child ,abuse ,prevention and ,treatment ,act 7#db ,u4,s4,c4 #eajf;a7d77 is amended by adding at the end of the following3 7#ag7 ,the total number of infants-- 7,a7 identified under subsection 7b77#b77;,b77ii72 7,b7 for whom a plan of safe care was developed under subsection 7b77#b77;,b77iii72 and 7,c7 for whom referrals are made for appropriate services1 including services for the affected family or caregiver1 as may be necessary under subsection 7b77#b77;,b77iii74 4 7b7 ,redesignation ,effective on ,may #bi1 #bjag1 section #ajf7;d7 of the ,child ,abuse ,prevention and ,treatment ,act 7#db ,u4,s4,c4 #eajf;a7d77 is amended by redesignating paragraph 7#ag7 7as added by subsection 7a77 as paragraph 7#ah74 #dje4 ,monitoring and oversight 7a7 ,amendment ,title ,i of the ,child ,abuse ,prevention and ,treatment ,act 7#db ,u4,s4,c4 #eaja et seq47 is further amended by adding at the end the following3 #aad4 ,monitoring and oversight ,the ,secretary shall conduct monitoring to ensure that each ,state that receives a grant under section #ajf is in compliance with the requirements of section #ajf7;b71 which-- 7#a7 shall-- 7,a7 be in addition to the review of the ,state plan upon its submission under section #ajf7;b77#a77;,a72 and 7,b7 include monitoring of ,state policies and procedures required under clauses 7ii7 and 7iii7 of section #ajf7;b77#b77;,b72 and 7#b7 may include-- 7,a7 a comparison of activities carried out by the ,state to comply with the requirements of section #ajf7;b7 with the ,state plan most recently approved under section #dcb of the ,social ,security ,act2 7,b7 information available on the ,website of the ,state relating to its compliance with the requirements of section #ajf7;b72 7,c7 site visits1 as may be necessary to carry out such monitoring2 and 7,d7 information available in the ,state's ,annual ,progress and ,services ,report most recently submitted under section #aceg4af of title #de1 ,code of ,federal ,regulations 7or successor regulations74 4 7b7 ,table of contents ,the table of contents in section #a7;b7 of the ,child ,abuse ,prevention and ,treatment ,act 7#db ,u4,s4,c4 #eaja note7 is amended by inserting after the item relating to section #aac1 the following3 ,sec4 #aad4 ,monitoring and oversight4 4 #djf4 ,rule of construction ,nothing in this ,act shall be construed to authorize the ,secretary of ,health and ,human ,services or any other officer of the ,federal ,government to add new requirements to section #ajf7;b7 of the ,child ,abuse ,prevention and ,treatment ,act 7#db ,u4,s4,c4 #eajf;a7b771 as amended by this ,act4 ,v ,other ,provisions #eja4 ,programs to prevent prescription drug abuse under ,medicare parts ,c and ,d 7a7 ,drug management program for at-,risk beneficiaries 7#a7 ,in general ,section #ahfj;,d-#d7;c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aj7;c77 is amended by adding at the end the following3 7#e7 ,drug management program for at-risk beneficiaries 7,a7 ,authority to establish ,a ,,pdp sponsor may establish a drug management program for at-risk beneficiaries under which1 subject to subparagraph 7,b71 the ,,pdp sponsor may1 in the case of an at-risk beneficiary for prescription drug abuse who is an enrollee in a prescription drug plan of such ,,pdp sponsor1 limit such beneficiary's access to coverage for frequently abused drugs under such plan to frequently abused drugs that are prescribed for such beneficiary by one or more prescribers selected under subparagraph 7,d71 and dispensed for such beneficiary by one or more pharmacies selected under such subparagraph4 7,b7 ,requirement for notices 7i7 ,in general ,a ,,pdp sponsor may not limit the access of an at-risk beneficiary for prescription drug abuse to coverage for frequently abused drugs under a prescription drug plan until such sponsor-- 7,i7 provides to the beneficiary an initial notice described in clause 7ii7 and a second notice described in clause 7iii72 and 7,,ii7 verifies with the providers of the beneficiary that the beneficiary is an at-risk beneficiary for prescription drug abuse4 7ii7 ,initial notice ,an initial notice described in this clause is a notice that provides to the beneficiary-- 7,i7 notice that the ,,pdp sponsor has identified the beneficiary as potentially being an at-risk beneficiary for prescription drug abuse2 7,,ii7 information describing all ,state and ,federal public health resources that are designed to address prescription drug abuse to which the beneficiary has access1 including mental health services and other counseling services2 7,,iii7 notice of1 and information about1 the right of the beneficiary to appeal such identification under subsection 7h7 and the option of an automatic escalation to external review2 7,,iv7 a request for the beneficiary to submit to the ,,pdp sponsor preferences for which prescribers and pharmacies the beneficiary would prefer the ,,pdp sponsor to select under subparagraph 7,d7 in the case that the beneficiary is identified as an at-risk beneficiary for prescription drug abuse as described in clause 7iii77,i72 7,v7 an explanation of the meaning and consequences of the identification of the beneficiary as potentially being an at-risk beneficiary for prescription drug abuse1 including an explanation of the drug management program established by the ,,pdp sponsor pursuant to subparagraph 7,a72 7,,vi7 clear instructions that explain how the beneficiary can contact the ,,pdp sponsor in order to submit to the ,,pdp sponsor the preferences described in subclause 7,,iv7 and any other communications relating to the drug management program for at-risk beneficiaries established by the ,,pdp sponsor2 and 7,,vii7 contact information for other organizations that can provide the beneficiary with assistance regarding such drug management program 7similar to the information provided by the ,secretary in other standardized notices provided to part ,d eligible individuals enrolled in prescription drug plans under this part74 7iii7 ,second notice ,a second notice described in this clause is a notice that provides to the beneficiary notice-- 7,i7 that the ,,pdp sponsor has identified the beneficiary as an at-risk beneficiary for prescription drug abuse2 7,,ii7 that such beneficiary is subject to the requirements of the drug management program for at-risk beneficiaries established by such ,,pdp sponsor for such plan2 7,,iii7 of the prescriber 7or prescribers7 and pharmacy 7or pharmacies7 selected for such individual under subparagraph 7,d72 7,,iv7 of1 and information about1 the beneficiary's right to appeal such identification under subsection 7h7 and the option of an automatic escalation to external review2 7,v7 that the beneficiary can1 in the case that the beneficiary has not previously submitted to the ,,pdp sponsor preferences for which prescribers and pharmacies the beneficiary would prefer the ,,pdp sponsor select under subparagraph 7,d71 submit such preferences to the ,,pdp sponsor2 and 7,,vi7 that includes clear instructions that explain how the beneficiary can contact the ,,pdp sponsor4 7iv7 ,timing of notices 7,i7 ,in general ,subject to subclause 7,,ii71 a second notice described in clause 7iii7 shall be provided to the beneficiary on a date that is not less than #fj days after an initial notice described in clause 7ii7 is provided to the beneficiary4 7,,ii7 ,exception ,in the case that the ,,pdp sponsor1 in conjunction with the ,secretary1 determines that concerns identified through rulemaking by the ,secretary regarding the health or safety of the beneficiary or regarding significant drug diversion activities require the ,,pdp sponsor to provide a second notice described in clause 7iii7 to the beneficiary on a date that is earlier than the date described in subclause 7,i71 the ,,pdp sponsor may provide such second notice on such earlier date4 7,c7 ,at-risk beneficiary for prescription drug abuse 7i7 ,in general ,for purposes of this paragraph1 the term at-risk beneficiary for prescription drug abuse means a part ,d eligible individual who is not an exempted individual described in clause 7ii7 and-- 7,i7 who is identified as such an at-risk beneficiary through the use of clinical guidelines developed by the ,secretary in consultation with ,,pdp sponsors and other stakeholders described in section #cada7;f77#b77;,a7 of the #bast ,century ,cures ,act2 or 7,,ii7 with respect to whom the ,,pdp sponsor of a prescription drug plan1 upon enrolling such individual in such plan1 received notice from the ,secretary that such individual was identified under this paragraph to be an at-risk beneficiary for prescription drug abuse under the prescription drug plan in which such individual was most recently previously enrolled and such identification has not been terminated under subparagraph 7,f74 7ii7 ,exempted individual described ,an exempted individual described in this clause is an individual who-- 7,i7 receives hospice care under this title2 7,,ii7 is a resident of a long-term care facility1 of an intermediate care facility for the mentally retarded1 or of another facility for which frequently abused drugs are dispensed for residents through a contract with a single pharmacy2 or 7,,iii7 the ,secretary elects to treat as an exempted individual for purposes of clause 7i74 7,d7 ,selection of prescribers and pharmacies 7i7 ,in general ,with respect to each at-risk beneficiary for prescription drug abuse enrolled in a prescription drug plan offered by such sponsor1 a ,,pdp sponsor shall1 based on the preferences submitted to the ,,pdp sponsor by the beneficiary pursuant to clauses 7ii77,,iv7 and 7iii77,v7 of subparagraph 7,b7 7except as otherwise provided in this subparagraph71 select-- 7,i7 one or more individuals who are authorized to prescribe frequently abused drugs 7referred to in this paragraph as prescribers7 who may write prescriptions for such drugs for such beneficiary2 and 7,,ii7 one or more pharmacies that may dispense such drugs to such beneficiary4 7ii7 ,reasonable access ,in making the selections under this subparagraph-- 7,i7 a ,,pdp sponsor shall ensure that the beneficiary continues to have reasonable access to frequently abused drugs 7as defined in subparagraph 7,g771 taking into account geographic location1 beneficiary preference1 impact on cost-sharing1 and reasonable travel time2 and 7,,ii7 a ,,pdp sponsor shall ensure such access 7including access to prescribers and pharmacies with respect to frequently abused drugs7 in the case of individuals with multiple residences and in the case of natural disasters and similar emergency situations4 7iii7 ,beneficiary preferences ,if an at-risk beneficiary for prescription drug abuse submits preferences for which in-network prescribers and pharmacies the beneficiary would prefer the ,,pdp sponsor select in response to a notice under subparagraph 7,b71 the ,,pdp sponsor shall-- 7,i7 review such preferences2 7,,ii7 select or change the selection of prescribers and pharmacies for the beneficiary based on such preferences2 and 7,,iii7 inform the beneficiary of such selection or change of selection4 7iv7 ,exception regarding beneficiary preferences ,in the case that the ,,pdp sponsor determines that a change to the selection of prescriber or pharmacy under clause 7iii77,,ii7 by the ,,pdp sponsor is contributing or would contribute to prescription drug abuse or drug diversion by the beneficiary1 the ,,pdp sponsor may change the selection of prescriber or pharmacy for the beneficiary without regard to the preferences of the beneficiary described in clause 7iii74 7v7 ,confirmation ,before selecting a prescriber 7or prescribers7 or pharmacy 7or pharmacies7 under this subparagraph1 a ,,pdp sponsor must request and receive confirmation from such a prescriber or pharmacy acknowledging and accepting that the beneficiary involved is in the drug management program for at-risk beneficiaries4 7,e7 ,terminations and appeals ,the identification of an individual as an at-risk beneficiary for prescription drug abuse under this paragraph1 a coverage determination made under a drug management program for at-risk beneficiaries1 and the selection of prescriber or pharmacy under subparagraph 7,d7 with respect to such individual shall be subject to reconsideration and appeal under subsection 7h7 and the option of an automatic escalation to external review to the extent provided by the ,secretary4 7,f7 ,termination of identification 7i7 ,in general ,the ,secretary shall develop standards for the termination of identification of an individual as an at-risk beneficiary for prescription drug abuse under this paragraph4 ,under such standards such identification shall terminate as of the earlier of-- 7,i7 the date the individual demonstrates that the individual is no longer likely1 in the absence of the restrictions under this paragraph1 to be an at-risk beneficiary for prescription drug abuse described in subparagraph 7,c77i72 and 7,,ii7 the end of such maximum period of identification as the ,secretary may specify4 7ii7 ,rule of construction ,nothing in clause 7i7 shall be construed as preventing a plan from identifying an individual as an at-risk beneficiary for prescription drug abuse under subparagraph 7,c77i7 after such termination on the basis of additional information on drug use occurring after the date of notice of such termination4 7,g7 ,frequently abused drug ,for purposes of this subsection1 the term frequently abused drug means a drug that is a controlled substance that the ,secretary determines to be frequently abused or diverted4 7,h7 ,data disclosure ,in the case of an at-risk beneficiary for prescription drug abuse whose access to coverage for frequently abused drugs under a prescription drug plan has been limited by a ,,pdp sponsor under this paragraph1 such ,,pdp sponsor shall disclose data1 including any necessary individually identifiable health information1 in a form and manner specified by the ,secretary1 about the decision to impose such limitations and the limitations imposed by the sponsor under this part to other ,,pdp sponsors that request such data4 7,i7 ,education ,the ,secretary shall provide education to enrollees in prescription drug plans of ,,pdp sponsors and providers regarding the drug management program for at-risk beneficiaries described in this paragraph1 including education-- 7i7 provided by ,medicare administrative contractors through the improper payment outreach and education program described in section #ahgd;,a7h72 and 7ii7 through current education efforts 7such as ,state health insurance assistance programs described in subsection 7a77#a77;,a7 of section #aai of the ,medicare ,improvements for ,patients and ,providers ,act of #bjjh 7#db ,u4,s4,c4 #acie;b-#c note77 and materials directed toward such enrollees4 7,j7 ,application under ,,ma-,,pd plans ,pursuant to section #ahfj;,d-#ba7;c77#a71 the provisions of this paragraph apply under part ,d to ,,ma organizations offering ,,ma-,,pd plans to ,,ma eligible individuals in the same manner as such provisions apply under this part to a ,,pdp sponsor offering a prescription drug plan to a part ,d eligible individual4 4 7#b7 ,information for consumers ,section #ahfj;,d-#d7;a77#a77;,b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#ajd7;a77#a77;,b77 is amended by adding at the end the following3 7v7 ,the drug management program for at-risk beneficiaries under subsection 7c77#e74 4 7b7 ,utilization management programs ,section #ahfj;,d-#d7;c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#ajd7;c771 as amended by subsection 7a77#a71 is further amended-- 7#a7 in paragraph 7#a71 by inserting after subparagraph 7,d7 the following new subparagraph3 7,e7 ,a utilization management tool to prevent drug abuse 7as described in paragraph 7#f77;,a774 2 and 7#b7 by adding at the end the following new paragraph3 7#f7 ,utilization management tool to prevent drug abuse 7,a7 ,in general ,a tool described in this paragraph is any of the following3 7i7 ,a utilization tool designed to prevent the abuse of frequently abused drugs by individuals and to prevent the diversion of such drugs at pharmacies4 7ii7 ,retrospective utilization review to identify-- 7,i7 individuals that receive frequently abused drugs at a frequency or in amounts that are not clinically appropriate2 and 7,,ii7 providers of services or suppliers that may facilitate the abuse or diversion of frequently abused drugs by beneficiaries4 7iii7 ,consultation with the contractor described in subparagraph 7,b7 to verify if an individual enrolling in a prescription drug plan offered by a ,,pdp sponsor has been previously identified by another ,,pdp sponsor as an individual described in clause 7ii77,i74 7,b7 ,reporting ,a ,,pdp sponsor offering a prescription drug plan 7and an ,,ma organization offering an ,,ma-,,pd plan7 in a ,state shall submit to the ,secretary and the ,medicare drug integrity contractor with which the ,secretary has entered into a contract under section #ahic with respect to such ,state a report1 on a monthly basis1 containing information on-- 7i7 any provider of services or supplier described in subparagraph 7,a77ii77,,ii7 that is identified by such plan sponsor 7or organization7 during the #cj-;day period before such report is submitted2 and 7ii7 the name and prescription records of individuals described in paragraph 7#e77;,c74 4 7c7 ,expanding ,activities of ,medicare ,drug ,integrity ,contractors 7,m,e,d,i,cs7 7#a7 ,in general ,section #ahic of the ,social ,security ,act 7#db ,u4,s4,c4 #acie;ddd7 is amended by adding at the end the following new subsection3 7j7 ,expanding ,activities of ,medicare ,drug ,integrity ,contractors 7,m,e,d,i,cs7 7#a7 ,access to information ,under contracts entered into under this section with ,medicare drug integrity contractors 7including any successor entity to a ,medicare drug integrity contractor71 the ,secretary shall authorize such contractors to directly accept prescription and necessary medical records from entities such as pharmacies1 prescription drug plans1 ,,ma-,,pd plans1 and physicians with respect to an individual in order for such contractors to provide information relevant to the determination of whether such individual is an at-risk beneficiary for prescription drug abuse1 as defined in section #ahfj;,d-#d7;c77#e77;,c74 7#b7 ,requirement for acknowledgment of referrals ,if a ,,pdp sponsor or ,,ma organization refers information to a contractor described in paragraph 7#a7 in order for such contractor to assist in the determination described in such paragraph1 the contractor shall-- 7,a7 acknowledge to the sponsor or organization receipt of the referral2 and 7,b7 in the case that any ,,pdp sponsor or ,,ma organization contacts the contractor requesting to know the determination by the contractor of whether or not an individual has been determined to be an individual described such paragraph1 shall inform such sponsor or organization of such determination on a date that is not later than #ae days after the date on which the sponsor or organization contacts the contractor4 7#c7 ,making data available to other entities 7,a7 ,in general ,for purposes of carrying out this subsection1 subject to subparagraph 7,b71 the ,secretary shall authorize ,m,e,d,i,cs to respond to requests for information from ,,pdp sponsors and ,,ma organizations1 ,state prescription drug monitoring programs1 and other entities delegated by such sponsors or organizations using available programs and systems in the effort to prevent fraud1 waste1 and abuse4 7,b7 ,,hipaa compliant information only ,information may only be disclosed by a ,,medic under subparagraph 7,a7 if the disclosure of such information is permitted under the ,federal regulations 7concerning the privacy of individually identifiable health information7 promulgated under section #bfd7;c7 of the ,health ,insurance ,portability and ,accountability ,act of #aiif 7#db ,u4,s4,c4 #acbj;d-#b note74 4 7#b7 ,,oig study and report on effectiveness of ,m,e,d,i,cs 7,a7 ,study ,the ,inspector ,general of the ,department of ,health and ,human ,services shall conduct a study on the effectiveness of ,medicare drug integrity contractors with which the ,secretary of ,health and ,human ,services has entered into a contract under section #ahic of the ,social ,security ,act 7#db ,u4,s4,c4 #acie;ddd7 in identifying1 combating1 and preventing fraud under the ,medicare ,program1 including under the authority provided under section #ahic7;j7 of the ,social ,security ,act1 added by paragraph 7#a74 7,b7 ,report ,not later than #a year after the date of the enactment of this ,act1 the ,inspector ,general shall submit to ,congress a report on the study conducted under subparagraph 7,a74 ,such report shall include such recommendations for improvements in the effectiveness of such contractors as the ,inspector ,general determines appropriate4 7d7 ,treatment of certain complaints for purposes of quality or performance assessment ,section #ahfj;,d-#db of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aeb7 is amended by adding at the end the following new subsection3 7d7 ,treatment of certain complaints for purposes of quality or performance assessment ,in conducting a quality or performance assessment of a ,,pdp sponsor1 the ,secretary shall develop or utilize existing screening methods for reviewing and considering complaints that are received from enrollees in a prescription drug plan offered by such ,,pdp sponsor and that are complaints regarding the lack of access by the individual to prescription drugs due to a drug management program for at-risk beneficiaries4 4 7e7 ,sense of congress regarding use of technology tools ,to combat fraud ,it is the sense of ,congress that ,,ma organizations and ,,pdp sponsors should consider using e-prescribing and other health information technology tools to support combating fraud under ,,ma-,,pd plans and prescription drug plans under parts ,c and ,d of the ,medicare ,program4 7f7 ,effective date 7#a7 ,in general ,the amendments made by this section shall apply to prescription drug plans 7and ,,ma-,,pd plans7 for plan years beginning more than #a year after the date of the enactment of this ,act4 7#b7 ,stakeholder meetings prior to effective date 7,a7 ,in general ,not later than ,january #a1 #bjaf1 the ,secretary of ,health and ,human ,services shall convene stakeholders1 including individuals entitled to benefits under part ,a of title ,,xviii of the ,social ,security ,act or enrolled under part ,b of such title of such ,act1 advocacy groups representing such individuals1 physicians1 pharmacists1 and other clinicians1 retail pharmacies1 plan sponsors1 entities delegated by plan sponsors1 and biopharmaceutical manufacturers for input regarding the topics described in subparagraph 7,b74 7,b7 ,topics described ,the topics described in this subparagraph are the topics of-- 7i7 the anticipated impact of drug management programs for at-risk beneficiaries under paragraph 7#e7 of section #ahfj;,d-#d7;c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#ajd7;c77 on cost-sharing and ensuring accessibility to prescription drugs for enrollees in prescription drug plans of ,,pdp sponsors1 and enrollees in ,,ma-,,pd plans1 who are at-risk beneficiaries for prescription drug abuse 7as defined in subparagraph 7,c7 of such paragraph72 7ii7 the use of an expedited appeals process under which such an enrollee may appeal an identification of such enrollee as an at-risk beneficiary for prescription drug abuse under such paragraph 7similar to the processes established under the ,medicare ,advantage program under part ,c of title ,,xviii of the ,social ,security ,act that allow an automatic escalation to external review of claims submitted under such part72 7iii7 the types of enrollees that should be treated as exempted individuals1 as described in subparagraph 7,c77ii7 of such paragraph2 7iv7 the manner in which terms and definitions in such paragraph should be applied1 such as the use of clinical appropriateness in determining whether an enrollee is an at-risk beneficiary for prescription drug abuse as defined in subparagraph 7,c7 of such paragraph2 7v7 the information to be included in the notices described in subparagraph 7,b7 of such paragraph and the standardization of such notices2 and 7vi7 with respect to a ,,pdp sponsor 7or ,medicare ,advantage organization7 that establishes a drug management program for at-risk beneficiaries under such paragraph1 the responsibilities of such ,,pdp sponsor 7or organization7 with respect to the implementation of such program4 7g7 ,rulemaking ,the ,secretary of ,health and ,human ,services shall promulgate regulations based on the input gathered pursuant to subsection 7f77#b77;,a74 #ejb4 ,exclusion of authorized generic drugs from calculation of average manufacturer price for brand name drugs 7a7 ,in general ,section #aibg7k77#a77;,c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acifr-#h7k77#a77;,c77 is amended-- 7#a7 in the subparagraph heading1 by striking ,inclusion and inserting ,exclusion2 7#b7 by striking a new drug application and inserting the manufacturer's new drug application2 and 7#c7 by striking inclusive and inserting exclusive4 7b7 ,effective date ,the amendments made by subsection 7a7 shall take effect one year after the date of the enactment of this section4